One and a half ventricle repair: clinical and animal study by Bhattarai, Anil
1 
 
 
 
 
UNIVERSITA DEGLI STUDI DI PADOVA 
 
Dipartimento di Scienze Cardiologiche, Toraciche e Vascolari 
______________________________________________________ 
 
SCUOLA DI DOTTORATO DI RICERCA IN SCIENZE MEDICHE, 
CLINICHE E SPERIMENTALI 
DOTTORATO DI RICERCA IN SCIENZE CARDIOVASCOLARI 
 
CICLO XXV 
 
 
 
 
TESI DI DOTTORATO 
 
ONE AND A HALF VENTRICLE REPAIR: 
CLINICAL AND ANIMAL STUDY 
 
 
 
Direttore della Scuola :         Ch.mo Prof. Gaetano Thiene 
 
Coordinatore d’indirizzo:     Ch.mo Prof. Gaetano Thiene 
 
Supervisore :                          Ch.mo Prof. Giovanni Stellin 
 
    
                                              Dottorando : Dr. Anil  Bhattarai 
 
 
 
 
2013 
2 
 
RIASSUNTO 
La prima descrizione della cosiddetta "correzione a un ventricolo e mezzo", fu 
pubblicato da Billingsly et al. nel 1989 
1
, Questo tipo di correzione è stato poi 
applicato in altri centri per correggere diverse anomalie congenite cardiache 
complesse caratterizzati da un ventricolo destro ipoplasico. La logica alla base di 
questa riparazione è duplice. Da un lato l'obiettivo è di ridurre il flusso di sangue, e 
quindi il pre-carico in, un ventricolo disfunzionale o ipoplasico destro (RV). D'altra 
parte la riparazione a un ventricolo e mezzo (1,5 VR) permette di mantenere una 
separazione completa e fisiologica della circolazione polmonare e sistemica, evitando 
mixing di sangue e desaturazione. Inoltre rappresenta una valida alternativa alla 
circolazione secondo Fontan nel contesto di una ipoplasia del ventricolo destro, 
fattore funzionale, con il vantaggio di fornire un flusso polmonare pulsatile e 
prevenire l’ipertensione venosa nel distretto della vena cava inferiore 2, 3. La 
correzione a un ventricolo e mezzo comprende la connessione della vena cava 
superiore all’arteria polmonare (shunt cavopolmonare bidirezionale), oltre a 
completare la chiusura di eventuali comunicazioni intracardiache, o meno alla 
riparazione di ulteriori difetti cardiaci congeniti associati. Questa metodica può essere 
applicata ad un ampio spettro di anomalie congenite, purché il ventricolo destro 
ipoplasico sia funzionalmente valido e pertanto in grado di gestire la portata di 
sangue della sola cava inferiore 
1, 4
. 
Questo studio è diviso in due parti: 
 1. Studio clinico 2. Studio sperimentale negli animali. 
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In questo studio abbiamo valutato i risultati del nostro Istituto a lungo termine e non 
solo della circolazione polmonare bifocale ma anche l’impatto delle malformazioni 
cardiache associate. Lo studio sugli animali e stato condotto nei conigli per valutare 
l'effetto del “pattern” pulsatile del flusso venoso in vena cava superiore e di capire i 
cambiamenti emodinamici in vena cava superiore, atrio destro, ventricolo destro, 
arteria polmonare e vena cava inferiore, nell’immediato e dopo stress test 
formacologico.  
A. Studio clinico 
Metodi 
Tutti i pazienti con correzione in uno ventricolo e mezzo tra il Marzo 1994 e Gennaio 
2012 sono stati inclusi. Tutti i dati clinici disponibili e operativi sono stati valutati. I 
pazienti sono stati suddivisi in: Gruppo A - pazienti con ventricolo destro ipoplasico / 
disfunzioni e malformazioni delle valvole tricuspide e polmonare, Gruppo B - 
pazienti con associate malformazioni complesse che coinvolgono altre strutture 
cardiache. 
Risultati 
Si tratta di un esame clinico retrospettivo di 18 anni in 24 pazienti consecutivi 
sottoposti a correzione un ventricolo e mezzo presso il nostro Istituto.  L'età  media di 
correzione  è  stata  di 11,9 anni  (range 4 mesi  -  66,8 anni).  Il Z-score medio  dell’ 
anello TV era -3,2 (range -6,2 a 3,6). Le resistenze vascolari polmonari medie erano 
1,75 U/m2 (range 1,0 - 3,0). Tre pazienti erano affetti da sindrome eterotassica. 
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Sedici pazienti erano stati sottoposti a precedenti interventi cardiaci, uno di questi 
aveva una deviazione atriopolmonare totale secondo Fontan. 
Le complicanze postoperatorie si sono verificate in 19 pazienti (79%): 
chilotorace/chylopericardium (n = 7), BAV III (n = 2), aritmie (n = 7), insufficienza 
renale (n = 4), insufficienza cardiaca (n = 4), cardiaca / versamento pleurico (n = 11), 
la sindrome di SVC (n = 2), infezione polmonare (n = 3), paralisi emi-diaframma che 
ha richiesto plastica diaframmatica (n = 1), trombosi SVC con PE (n = 1). Cinque 
pazienti hanno richiesto l'impianto definitivo di PM. Tutti i pazienti sono sopravissuti 
e dopo una degenza media di 32 ± 29 giorni. Ad un follow up medio di 8,3 anni 
(range 1 mese - 17,9 anni, la completezza FU: 96%), ci sono stati 2 morti tardive (1 
non cardiaca). Tra i sopravvissuti, lo stato funzionale prevalente era NYHA classe I 
in 19 pazienti (90,4%). Eventi avversi tardivi si sono verificati in 10 pazienti (43%) 
tra cui: un nuovo intervento(n = 3), uno di questi era una conversione biventricolare; 
procedure emodinamiche (n = 6), aritmie (n = 2), eventi neurologici 
 (n = 1 ); altre complicazioni (n = 5). 
La libertà totale da eventi avversi, la chirurgia e le procedure interventistiche sono 
state 56,5%, 87% e 73,9% rispettivamente. La libertà da eventi avversi nel gruppo A 
(n = 12) è stata 83,3%, mentre nel gruppo B (n = 11) è stata pari al 27,3%. L'analisi 
statistica ha dimostrato che il Gruppo B ha avuto una libertà significativamente più 
basse di eventi avversi rispetto al gruppo A (p = 0,015). 
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B. Studio degli animali 
Metodi 
Esperimento è stato eseguito in conigli. La cura degli animali e stata svolta secondo 
lo standard stabilito per gli studi sperimentali. 
Modello sperimentale: CONIGLIO 
Strain: NUOVA ZELANDA 
Numero totale Animali: 30 
 Peso di animali: 4. 5-5,5 kg 
Risultati 
1. Dopo anastomosi cavopolmonare- la pressione in SVC  risultava aumentata ma la 
pressione in RA invece diminuiva, il che dimostra la diminuzione della pressione 
nella vena cava inferiore. 
2. Dopo lo stress indotto farmacologicamente: la pressione nella vena cava superiore 
e la frequenza cardiaca aumentavano, mentre la pressione del ventricolo destro, atrio 
destro e la pressione in arteria polmonare rimanevano simili come in condizione di 
riposo dopo un’anastomosi cavo polmonare. 
3. Ciò significa che la pressione della vena cava superiore è sempre più elevata dopo 
anastomosi cavapulmonare ma la pressione venosa nella vena cava inferiore  è 
costante e ancora più bassa se confrontato alla pressione preoperatoria. 
4. Non abbiamo trovato alcuna modifica della pressione atriale destra, dopo 
correzione ad un ventricolo e mezzo; anche dopo stress test farmacologico viene  
dimostrato che il ritorno dalla vena cava inferiore è adeguato e non esiste ipertensione 
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in vena cava inferiore, (buona tolleranza fisica). Questo è un risultato molto positivo 
a favore della correzione a un ventricolo e mezzo ventricolo rispetto all’ intervento di 
Fontan. 
Conclusione 
Si conclude che la correzione 1,5 VR è una scelta sicura e valida per la riparazione 
chirurgica dell’ipoplasia del ventricolo destro associato o meno ad altre 
malformazioni cardiache come alternativa alla procedura di Fontan. La maggior parte 
dei pazienti mostrano un buono stato funzionale al follow-up. Questa riparazione 
mantiene una bassa pressione nella vena cava inferiore  e permette buoni risultati 
precoci e a medio termine. 
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SUMMARY 
Since the first description of the so called “one and a half ventricle repair”, published 
by Billingsly et al. in 1989 
1
, this type of correction has been applied to several 
complex congenital cardiac anomalies. The rationale underlying this repair is 
twofold. On one hand the aim is to reduce the blood flow to, and therefore to 
downsize the pre-load of, a dysfunctional or hypoplastic right ventricle (RV), 
considered to be unable to sustain a biventricular correction. On the other hand the 
one and a half ventricle repair (1.5 VR) permits to maintain a complete and 
physiological separation of pulmonary and systemic circulations, avoiding blood 
mixing and desaturation. Furthermore it represents a valid alternative to the Fontan 
circulation in the setting of a less but still functioning RV, with the advantage to 
provide a pulsatile pulmonary blood flow and to prevent systemic venous 
hypertension 
2,3
. One and a half ventricle repair consists of bidirectional cavo-
pulmonary shunt (BCPS) in addition to complete closure of intracardiac 
communications, associated or not with repair of other congenital heart defects. It can 
be appropriate for a wide spectrum of congenital anomalies, provided that the RV is 
large enough to manage the blood supply from the inferior vena cava. However, 
feasibility in adult population is being explored 
1,4
. 
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This study has divided in two parts:  
1. Clinical study 2. Experimental study in animals.  
In clinical study we have reviewed our institutional experience with 1.5 VR to 
evaluate early and long term results and explore the impact of associated cardiac 
malformations on outcomes of the one and a half ventricle repair. Animal study in 
rabbits was conducted to evaluate the effect of a pulsatile venous flow pattern in 
superior vena cava and to understand an immediate & after pharmacologically 
induced stress test the hemodynamic changes in superior vena cava, right atrium, 
right ventricle, pulmonary artery and inferior vena cava district. 
A. Clinical study 
Methods 
All patients who underwent one and a half ventricle repair between March 1994 and  
January 2012 were included. All available clinical and operative data were reviewed. 
Patients were divided in: Group A - patients with right ventricle 
hypoplasia/dysfunction and malformations of  tricuspid or pulmonary valves; Group 
B - patients with associated complex malformations involving other cardiac 
structures. 
Results 
This is an 18 years retrospective clinical review of 24 consecutive patients who 
underwent one and a half ventricle repair at our Institution. Mean age at repair was 
11.9 years (range 4 months – 66.8 years). Mean TV annulus Z-score was -3.2 (range -
6.2 to 3.6). Mean pulmonary vascular resistance was 1.75 U/m2 (range 1.0 to 3.0). 
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Three patients had heterotaxy syndrome. Sixteen patients underwent previous cardiac 
operation, one of these had a Fontan operation. 
There was no death at operation. Postoperative complications occurred in 19 patients 
(79 %), and were: chylothorax/chylopericardium (n=7), BAV III (n=2), arrhythmias 
(n=7), renal failure (n=4), heart failure (n=4), cardiac/pleural effusion (n=11), SVC 
syndrome (n=2), pulmonary infection (n=3), hemi diaphragm paralysis that required 
diaphragm plasty (n=1), SVC thrombosis with PE (n=1). Five patients required 
definitive PM implantation. All patients were discharged home alive and well, after a 
mean hospital stay of 32 ± 29 days. At a mean follow up of 8.3 years (range 1 month 
– 17.9 years, FU completeness: 96 %), there were 2 late deaths (1 non cardiac 
related). Among survivors, functional status was NYHA class I in 19 patients 
(90.4%). Late adverse events occurred in 10 patients (43 %) including: late 
reoperation (n=3), one of these was a biventricular conversion; haemodynamic 
procedures (n=6); arrhythmias (n=2); neurological event (n=1); other complications 
(n=5).  
Overall freedom from adverse events, surgery and interventional procedures was 56.5 
%, 87 % and 73,9 % respectively. Freedom from adverse event in Group A (n=12) 
was 83.3 % while in Group B (n=11) was 27.3 %. Statistical analysis demonstrated 
that Group B had a significantly lower freedom from adverse events than Group A (p 
= 0.015). 
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B. Animal Study 
Methods 
Experiment was performed in experimental Rabbits. Animal care has taken according 
to established standard for experiment in animals.  
Experimental model: RABBIT 
Strain:  NEW ZEALAND 
Total animal number: 30 
 Weigh of animals:4. 5-5.5 kg 
Results 
1. After cavapulmonary anastomosis- SVC and PA pressure has increased but   RA    
pressure has decreased, which proves the decrease of the pressure in inferior vena 
cava district. 
2. After pharmacologically induced stress test:  increased the pressure in superior 
vena cava and also increased heart rate but  right ventricular, right atrial & pulmonary 
artery pressures were remained as same as after cavopolmonary anastomosis, as it is 
in resting condition. 
3. That means superior vena cava pressure is always higher after cavapulmonary 
anastomosis but venous pressure in inferior vena cava district is constant and even 
lower in comparison with preoperative pressure. 
4. We found no any changes of right atrial pressure, after 1.5 ventricular repair and 
even after pharmacologically induced stress test which proves that the inferior vena 
cava return is ok and no hypertension in inferior vena cava district even after stress 
11 
 
test(good exercise tolerance), which is  a very positive finding in favour of one and a 
half ventricle repair in comparison to Fontan type procedure. 
Conclusion  
After having the result of both clinical study and experiment in animals we have 
concluded that the 1.5 VR is a safe and valid option for surgical repair of hypoplasic, 
borderline or failing right ventricles as an alternative to Fontan procedure. Most 
patients show good functional status at follow up. This repair provides  a low 
pressure in the inferior vena cava district and allows good early and mid-term 
outcomes. 
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ABBREVIATION 
 
1.5VR = One and a half ventricle repair 
ASD = Atrial septal defect 
A-V = Atrio- ventricular   
AV canal = Atrio ventricular canal 
BCPS = Bidirectional cavopulmonary shunt 
CHD = Congenital heart disease  
CPA = Cavopulmonary anastomosis 
CVPA = Cavopulmonary anastomosis 
DORV = Double outlet right ventricle  
IVC = Inferior vena cava 
LPA = Left pulmonary artery  
LSVC = Left superior vena cava 
MPA = Main pulmonary artery  
MRI = Magnetic Resonance Imaging 
MUF = Modified ultrafiltration  
PA = Pulmonary artery 
PAPVR = Partial anomalous pulmonary venous return 
PDA = Patent ductus arteriosus 
PFO = Patent fossa ovalis 
PVR = Pulmonary vascular resistance  
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RPA = right pulmonary artery  
RSVC = Right superior vena cava  
RV = Right ventricle 
RVOT = Right ventricle outflow tract  
RVOTO = Right ventricle outflow tract obstruction 
SVC = Superior vena cava 
TCPC = Total cavopulmonary anastomosis 
TGA = Transposition of the great arteries  
TV = Tricuspid valve  
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SECTION I 
 
 
 
 
 
 
 
GENERAL OVERVIEW 
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A. HISTORICAL NOTES 
 
 
Fig.1 Dr Carlon 
 
 
Fig.2: Ann Thorac Surg 1999; 67:1175 
 
Carlon (of Padova) employed his shunt (Fig 2A) in a canine model 
5
. His 1951 description noted 
some of the technical and physiologic advantages of this alternative to the Blalock shunt. The 
azygos vein was used to connect the right pulmonary artery to the superior vena cava, and the 
proximal right pulmonary artery and superior vena cava were ligated. Azzolina (of Massa) extended 
this concept to a bidirectional shunt (Fig 2B), which was employed in 9 patients with tricuspid 
atresia, the youngest just 5 months of age 
6
. The clinical work was carried out between 1968 and 
1970.  
18 
 
 
Fig.3: Billingsly AM, Laks H, Boyce SW.  J Thorac Cardiovasc Surg 1989; 97:746-54 
 
The Azzolina shunt was performed through a right thoracotomy, and without bypass, using a side-
to-side anastomosis. An interesting feature was the use of an adjustable snare on the proximal 
superior vena cava. 
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B.INTRODUCTION 
Congenital heart disease (CHD) is one of the most common inborn defects, with an 
extimated incidence of 8/1000 live newborns. Cardiac malformations are currently treated in the 
pediatric age, with an overall early surgical mortality inferior to 5%.
7
  Prior to advent of surgery, 
less than 20% of children with congenital heart malformations survived to adult life.
8
 Since the late 
‘60s, the extraordinary advances in cardiac surgery, intensive care and non-invasive diagnosis have 
drastically modified the natural history of almost all CHD. Currently, most deaths for CHD occur in 
adults, who may have had or not repair or any kind of surgery. In fact, approximately 85% of babies 
born with cardiovascular anomalies can expect to reach adulthood, and with continued 
improvement in surgical technique, this could increase further in the next future.
9
 This improvement 
has selected a growing number of newborns and infants who have survived through adolescence, 
until adulthood. 
10 
 
In this contest patients with single ventricle physiology or with borderline right ventricle are still 
challenging cases for pediatric cardiac surgeons. One and a half ventricle repair, in which intra-
cardiac repair is supplemented by bidirectional cavopulmonary anastomosis, may be a valuable 
concept in management of patients with a failing right ventricular circulation.
11
 Patients with 
borderline right ventricle can be the candidate for one and a half ventricle repair like in case of right 
ventricular outflow obstruction with right ventricular hypoplasia, straddling tricuspid valve, 
pulmonary atresia with intact ventricular septum, rare variants of Tetralogy of Fallot, tricuspid 
valve stenosis with ventricular septal defect and Ebstein’s anomaly. In all these above mentioned 
pathological conditions important is to understand pre operatively, whether the right ventricular 
function and volume is adequate for one and a half ventricle repair.  
There are many different classifications of congenital heart diseases are available in literature. Most 
of the classifications are based on physiology and pathophysiology of the congenital heart diseases. 
20 
 
Among recent classifications, the most recent one is reported from the International Society for 
Nomenclature of Pediatric and Congenital Heart Disease.
12
  which is a  Physiological 
classification of congenital heart disease: 
1. ‘Simple’ left-to-right shunt lesions: these cause an increased 
      pulmonary blood flow 
a. Atrial septal defect 
b. Ventricular septal defect 
c. Atrioventricular septal defect 
d. Patent ductus arteriosus 
e. Aortopulmonary window 
NB The effect of the shunt on right ventricular and respiratory physiology differs depending on the 
level at which shunting occurs. 
2. ‘Simple’ right-to-left shunt lesions: these cause a reduction in pulmonary blood 
     flow with cyanosis 
a. Tetralogy of Fallot. Consists of right ventricular outflow tractobstruction, right ventricular 
     hypertrophy, ventricular septal defect and an overriding of the aorta 
b. Pulmonary atresia 
c. Tricuspid atresia 
d. Ebstein’s anomaly. Consists of downward displacement of an abnormal tricuspid valve into the 
right ventricular cavity, part of the right ventricle is thus incorporated into the right atrium 
(atrialized right ventricle), and the remaining right ventricular cavity is malformed 
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3. Complex shunts: these cause mixing of pulmonary blood flow and systemic blood flow. 
Cyanosis occurs as a result of complex interactions between systemic vascular resistance and 
pulmonary vascular resistance 
a. Transposition of the great arteries 
b. Truncus arteriosus 
c. Total anomalous pulmonary venous drainage 
d. Double-outlet right ventricle 
e. Hypoplastic left heart syndrome 
Most of these lesions (except total anomalous pulmonary venous drainage) are examples of a 
parallel circulation. 
4. Obstructive lesions 
a. Coarctation of the aorta 
b. Interrupted aortic arch 
c. Aortic stenosis 
d. Pulmonary stenosis 
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C. PATHOPHYSIOLOGICAL CLASSIFICATION OF CHD  
(G. Thiene & C. Frescura –Padova) 
Researchers from Padova, group of Professor Gaetano Thiene and Carla Frescura classified 
congenital heart diseases from pathophysiological point of view in their recent publication. 
13
 
 
Fig.4: Prof. Gaetano Thiene 
 
1.CHD with increased pulmonary blood flow (septal defects without pulmonary obstruction 
   and left-to right shunt): Partially anomalous pulmonary venous drainage, ASD, complete AV 
canal, VSD, Truncus arteriosus. 
 
2. CHD with decreased pulmonary flow (septal defects with pulmonary obstruction and right-to-left 
shunt): Pulmonary stenosis with ASD, pulmonary stenosis with VSD(Tetralogy of Fallot), tricuspid 
valve atresia, Ebstein’s anomaly, single or double inlet ventricle with pulmonary stenosis. 
 
3. CHD with obstruction to blood progression and no septal defects (no shunt): Pulmonary valve 
stenosis, Aortic valve stenosis, aortic coarctation.  
 4. CHD so severe as to be incompatible with postnatal blood circulation: 
Ductus dependent (pulmonary atresia, aortic and mitral atresia), interrupted aortic arch, atretic 
aortic arch, complete TGA, anomalous connection/ obstruction of the pulmonary veins. 
5. CHD silent until adult age: 
23 
 
Bicuspid aortic valve, congenital anomalous coronary arteries, wolff- Prkinson – White syndrome, 
congenitally corrected TGA. According to both of the classifications patients with right ventricular 
hypoplasia belongs to the group of the patients with decreased pulmonary flow like; Ebstain’s 
anomaly, tricuspid atresia, single or double inlet ventricle with pulmonary stenosis. 
 
Fig.5:  G.Thiene, C Frescura (cardiovascular pathology (2010) 
Univentricular AV connection. (A) AV connection is univentricular when both atria drain mostly (N75%) into a 
single ventricular chamber through two patent valves or a common AV valve (double-inlet connection), or 
through a single patent valve in case of absent right or left connection. (B) Specimen with absent right AV 
connection (tricuspid atresia), viewed from the right atrium: no tricuspid valve is present in the atrial floor. (C) 
Specimen with double-inlet ventricle: both the mitral valve and the tricuspid valve drain into a morphologically 
left ventricle. (D) Specimen with absent left AV connection (mitral atresia): the mitral valve is absent, and the 
left cardiac chambers are hypoplastic. A: atrium; V: ventricle; IV: indeterminate ventricle; LV: left ventricle; 
RV: right ventricle. 
24 
 
Similarly, to have a general concept on pathophysiology of the congenital heart diseases   
anatomical collection of the congenital cardiac defects at Padova University are valuable.  In the 
book of Prof. G. Thiene and colleagues well described the pathophysiological anatomy of different 
types of congenital cardiac diseases. According to this concept the first step in the segmental 
approach to diagnose congenital heart defect is to establish the platform of the heart, namely, the 
atrial situs and venous drainage.
14
  Patients with single heart physiology including right ventricular 
hypoplasia with heterotaxy syndrome (asplenia or polisplenia)  are significantly high risk patients 
for Fontan type palliation or even for 1.5 ventricle repair, which are also the findings of this study in 
patients with right ventricular hypoplasia. 
In this contest it is considerable to have a general overview on different types of sequential chamber 
localization  to understand the proper anatomy in patients with heterotaxy  syndrome.  
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Sequential chamber localization 
 
Fig.6: Carla Frescura, Siew Yen Ho,  Gaetano Thiene 
La collezione anatomica di cardiopatie congenite dell’ Universita di Padova 1996 
Atrial situs. (A) In situs solitus, the morphologically right atrium is located on the right side, and the 
morphologically left atrium is located on the left side; the trilobed lung and short bronchus are on the right side; 
and the bilobed lung and long bronchus are on the left side. (B) Situs inversus is the mirror image of situs solitus, 
with a reverse position of the atria and lungs. (C) In right atrial isomerism, both atria are of right morphology, 
the lungs are bilaterally trilobed, and the bronchi are short. Under the diaphragm, there is heterotaxia of 
abdominal organs, and the spleen tends to be absent (asplenia syndrome). (D) In left atrial isomerism, both atria 
present a left morphology, and the lungs are bilaterally bilobed with long bronchi. Under the diaphragm, there is 
heterotaxia of abdominal organs with multiple spleens (polysplenia syndrome). 
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SECTION II 
 
 
 
 
CONGENITAL HEART DISEASES ASSOCIATED 
WITH RIGHT VENTRICLE HYPOPLASIA 
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Congenital heart diseases associated with right ventricle hypoplasia 
 
 
Fig.7:  Right ventricle hypoplasia 
 
A hypoplastic but potentially or partially usable right ventricle occurs in a variety of clinical 
situations. The disease spectrum includes patients with (1) ) Ebstein’s anomaly; (2) right ventricular 
outflow tract obstruction and a hypoplastic right ventricle; (3) pulmonary atresia with intact 
ventricular septum; (4) rare variants of tetralogy of Fallot; (5) tricuspid stenosis with atrial septal 
defect; (6) inlet ventricular septal defect and a straddling tricuspid valve; and (7) complete 
atrioventricular canal with (a) extreme left ventricular dominance, (b) tetralogy of Fallot, (c) double 
outlet of the right ventricle, or (d) pulmonary stenosis. When right ventricular hypoplasia is 
diagnoses in association with other congenital anomalies, pediatric cardiac surgeons are working to 
develop a more reliable and optimal surgical techniques to unload the right ventricle and increase 
the blood flow to the lungs.  
28 
 
Right ventricle hypoplasia can be associated to a wide spectrum of complex congenital cardiac 
malformations. All these anomalies are characterized by a normal functioning left ventricle, and a 
hypoplasic right ventricle which is not able to manage the whole cardiac output resulting in a 
various degree of inadequate blood flow to the lungs and signs of right ventricular failure.  
Treatment strategies for these groups of patients include (1) the bidirectional Glenn shunt, (2) a 
Fontan type of repair, or (3) a biventricular repair with atrial septal fenestration and (4) 1.5 ventricle 
repair. 
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A. EBSTAIN’S ANOMALY 
 
 
Fig.8: Ebstein’s anomaly 
 
Ebstein’s anomaly of the tricuspid valve is a rare congenital malformation that accounts for less 
than 1% of all congenital heart defects 
15-26
. The essence of the malformation is the downward 
displacement of the septal and part or whole of the posterior leaflets into the inlet portion. The 
apposition of the tricuspid leaflets is displaced towards the infundibulum and the apical trabecular 
portion of the right ventricle, creating the distal orifice of the tricuspid funnel.  
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The part of the right ventricle beyond is the functional right ventricle; the part upstream is the 
atrialized inlet portion of the right ventricle (Figure 8). The tricuspid valve is often incompetent 
and, at the level of the distal orifice, sometimes stenotic. The anterosuperior leaflet seems to be in 
continuity with the posterior leaflet, without a clear commissure or attachment to the tricuspid 
annulus.  
Often it is large and thin. Close to the anteroseptal commissure, the leaflet is usually freely mobile 
but as the observer scans towards the posterior leaflet, the ventricular part of the valve tends to be 
tethered and then fused to the right ventricular free wall, while the hinge point itself becomes 
progressively displaced towards the apex of the right ventricle and away from the tricuspid annulus. 
There is marked obliteration of the interchordal space, almost constituting a veil. Rarely, the normal 
anterior and medial papillary muscles can be identified; more often, the anterior leaflet is attached 
directly to the right ventricle cavity 
16
. 
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SURGICAL ANATOMY 
Ebstein’s anomaly has three characteristic features: (a) a downward displacement of the septal and 
posterior leaflets into the right ventricle; (b) an atrialized portion of the right ventricle between the 
tricuspid annulus and the attachment of the posterior and septal leaflets (inlet portion); and (c) a 
malformation of the right ventricle, where the functional right ventricle is small and thin-walled and 
often has an abnormal systolic function. The trabecular portion is reduced; the infundibular portion 
may be partially obstructed by excess valvar tissue attachments of the anterior leaflet to the 
infundibulum. This is best appreciated with magnetic resonance imaging (MRI). Depending on the 
severity of these malformations, Ebstein’s anomaly can be categorized into four types27.  
(Figure 9): types of Ebstein’s anomaly 
 
 
• Type a. The anomaly is limited to the displacement of the septal leaflet with a small atrialized 
chamber. The anterior leaflet is large, moves freely and has a free leading edge between the 
anteroseptal and anterolateral commissures. (illustrated on Figure 9). 
• Type b. The anterior leaflet is restricted, with some interchordal space obliteration and attachment 
of the ventricular surface to the ventricle by fibrous bands. The posterolateral and anteroseptal 
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commissures are clearly delineated, the latter serving as a communication between the atrialized 
chamber and the functional right ventricle. The atrialized chamber is large Figure (9.b). 
• Type c. The anterior leaflet is partially fused to the infundibulum and the trabecular portion of the 
ventricular edge of the valve is adherent to the ventricle, in continuity with the adherent septal and 
posterior leaflets. There is a marked displacement 
of the posterior and septal leaflets, which may be severely hypoplastic. The atrialized chamber is 
large and has a thin, non-contractile wall. The functional right ventricle is small and its contractility 
may be diminished (Figure 9.c).  
• Type d. No anterior or posterior leaflets can be recognized, as they are totally adherent to the 
ventricular wall. The tricuspid orifice is deeply displaced towards the infundibulum and is often 
stenotic. The right ventricle is entirely made of the atrialized chamber.  
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B. RIGHT VENTRICULAR OUTFLOW TRACT OBSTRUCTION  
        AND HYPOPLASTIC RIGHT VENTRICLE 
Pulmonary stenosis and pulmonary atresia with intact ventricular septum are classically described 
as two separate entities. However, there is a consensus that in the neonatal period, critical 
pulmonary stenosis and pulmonary atresia often have a similar clinical presentation, and hearts with 
pinhole pulmonary stenosis may indeed exhibit the anatomical features of right ventricular (RV) 
hypertrophy and cavity hypoplasia commonly seen in pulmonary atresia with intact ventricular 
septum. Right ventricular outflow tract obstruction (RVOTO) without RV hypertrophy is also 
included.  
Anatomical Substrate: 
Pulmonary Valve 
In pulmonary atresia, the pulmonary valve is replaced by an imperforate, fibrous membrane. In 
some cases, prominent commissural ridges converge and meet at the centre of the imperforate 
valve. This is the form of imperforate valve observed in patients with severe infundibular stenosis 
or atresia. The other type of imperforate pulmonary valve is characterized by commissural ridges 
present only at the periphery of the valve, the centre being a smooth fibrous membrane, having the 
potential to bulge into the pulmonary trunk. This type of valve is usually associated with a lesser 
degree of right ventricular hypoplasia and with an open infundibulum.
28
 In severe pulmonary 
stenosis, there is commissural fusion at the periphery of the valve. Centrally, there is a smooth 
fibrous dome with an orifice that is usually central but sometimes eccentric. In less severe forms, 
two, three or sometimes four leaflets are relatively well formed, with only partial commissural 
fusion. The valve is usually thickened and may have a myxomatous appearance, particularly in 
neonates and small infants. Pulmonary stenosis due to mucoid thickening of the valve leaflets 
without commissural fusion is known as pulmonary valvular dysplasia. The valve ‘‘ring’’ may or 
may not be hypoplastic. Hypoplastic ring is often seen in the Noonan syndrome. 
29
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Pulmonary Arteries 
A good-sized main pulmonary artery with confluent branches is the usual situation in pulmonary 
atresia with intact ventricular septum. Beyond infancy, post stenotic dilatation of the main and 
proximal left pulmonary arteries is a common finding in patients with pulmonary stenosis. Stenosis 
of pulmonary arterial branches can occur in isolation or in association with other cardiac 
malformations. These can be central or peripheral, discrete or tubular, single or multiple. Multiple 
peripheral pulmonary stenosis are often a part of the rubella syndrome. Right Ventricle and 
Tricuspid Valve in pulmonary atresia with intact ventricular septum, right ventricular cavity size is 
variable with different degrees of myocardial hypertrophy and tricuspid valve anomalies. Most 
patients have both right ventricular hypoplasia and hypertrophy, both of which may be severe. In 
these hearts, the size of the tricuspid valve annulus has been found to relate to the degree of cavity 
hypoplasia. In addition, the tricuspid valve leaflets are often thickened and chordae are abnormal in 
number and attachments. At the other end of the spectrum are those hearts with greatly enlarged 
right ventricular cavities and a regurgitant dysplastic tricuspid valve, with or without displacement 
(Ebstein’s anomaly). In this rare anomaly the right ventricular wall is usually thinned and, on 
occasion, may be devoid of myocardium (Uhl’s anomaly and pulmonary atresia). In valvar 
pulmonary stenosis, the obstruction produces concentric hypertrophy of the right ventricle, which 
may result in secondary infundibular stenosis. There is usually mild to moderate reduction in right 
ventricular cavity size, which is partly related to the concentric ventricular hypertrophy. Severe 
right ventricular hypoplasia or enlargement is rare. Isolated subvalvar pulmonary stenosis produced 
by a large anomalous muscle bands account for 10–20% of patients with pulmonary stenosis and 
intact ventricular septum. 
30
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Right Atrium 
An atrial communication is present in all cases of pulmonary atresia with intact ventricular septum 
and in most neonates with critical pulmonary stenosis. The communication is restrictive in about 5–
10% of neonates with pulmonary atresia with intact ventricular septum.
31
  
Coronary Arteries 
A substantial number of patients with pulmonary atresia with intact ventricular septum and 
diminutive and hypertensive right ventricle have persistence of right ventricular myocardial 
sinusoidal coronary artery connections. 
31,32
  The fistulous communications can connect the 
hypertensive right ventricle to one or both coronary arteries. Connection to the left anterior 
descending coronary artery is the commonest. Sometimes the proximal connection between the 
coronary artery and the aorta is absent, and perfusion of the involved coronary circulation is 
retrograde from the right ventricle and is dependent on right ventricular hypertension (right 
ventricular-dependent coronary circulation). Intimal fibromuscular hyperplasia often occurs in the 
coronary arteries linked with the sinusoids and may be responsible for myocardial ischemia and 
infarction, involving either the right or the left ventricle or both. 
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Principles of surgical management 
In recent years, a more aggressive approach towards early relief of right ventricular outflow 
obstruction was adopted. The aim is to provide pulmonary forward flow and stimulate right 
ventricular growth and enable the right ventricle to serve the pulmonary circulation whenever 
possible. In addition, there is good evidence that left ventricular function can be compromised by 
the presence of a hypertrophied, hypertensive right ventricle. 
31, 33
  We feel that right ventricular 
decompression should be considered, even if the right ventricle is too small to be incorporated later 
into a biventricular circulation. However, the right ventricle should not be decompressed in the 
presence of a right ventricular-dependent coronary circulation. Under these circumstances, the high-
pressure right ventricle perfuses portions of the right and left ventricular myocardium with 
desaturated blood in systole. During diastole, the lower right ventricular diastolic pressure may 
allow a steal of blood from the coronary arteries into the right ventricle, to the detriment of the 
coronary circulation. Furthermore, the coronary circulation may be right ventricular-dependent in 
the case of a proximal discontinuity between one or both coronary arteries and the aorta and/or in 
the case of peripheral stenosis caused by intimal hyperplasia. Decompression of such ventricles may 
result in myocardial ischemia and/or infarction in the distribution of the involved coronary arteries. 
The decision between univentricular and biventricular repair depends on the morphological 
characteristics of the right ventricle, in particular the size of the right ventricular cavity and the 
presence or absence of coronary artery fistulae. The adequacy of the hypoplastic right ventricle for 
biventricular repair is difficult to assess and different methods have been used.  
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In patients with pulmonary atresia and intact ventricular septum, we have found it useful to classify 
the hypoplastic, hypertrophied right ventricles into three categories on the basis of the tripartite 
concept of the right ventricle 
34,35 
 the hearts with all three components present; those with the 
absence of the trabecular portion; and those with an inlet zone only.  
In these hearts, the size of the tricuspid valve annulus was found to relate to the degree of cavity 
obliteration. Studies of De Leval et al, 
36
 have suggested that a right ventricle whose tricuspid valve 
diameter is within 99% (three standard deviations) of mean normal is capable of providing adequate 
pulmonary blood flow and of being incorporated into a biventricular circulation. Our initial 
measurements of the tricuspid valve diameter were made on angiocardiograms. Currently they are 
made on two-dimensional (2D) echocardiograms. (Table 1) gives the mean normal values for a 
given body weight and their lower 99% confidence limits. The mean normals were derived from the 
studies of Rowlatt and adjusted by Bull et al.
35
 and Hanley et al.
37
 suggested using the z 
value(standard deviation units) of the tricuspid valve diameter. 
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Table .1:  Measurements of valve diameter used in decision making. 
Weight (kg)                          Angiographically estimated diameter of  tricuspid valve (mm) 
                                     ----------------------------------------------------------------------------------------- 
                                              Normal mean∗                                    Lower 99% CL 
2                                                    13                                                         5 
3                                                    16                                                         8 
4                                                    19                                                        11 
5                                                    20                                                        12 
6                                                    22                                                        14 
7                                                    23                                                        15 
8                                                    25                                                          1 
9                                                    26                                                         18 
10                                                  27                                                         19 
12                                                  28                                                         20 
14                                                  29                                                         21 
16                                                  30                                                         22 
18                                                  31                                                         23 
20                                                  32                                                         24 
25                                                  34                                                         26 
30                                                  36                                                         28 
CL, confidence limit. 
∗ Derived from autopsy data of Rowlatt et al. (1963). 38 
Adjusted for angiographic assessment according to Bull et al. (1982). 
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Fig.10. (J. Stark and V. T. Tsang.) 
 
calculated as follows: 
z value =         measured diameter − mean normal diameter 
                      ------------------------------------------------------------               
                     standard deviation of mean normal diameter 
 
The normal diameter is the diameter in a normal individual of the same body surface area. The data 
for the mean normal diameters and their standard deviations also come from the anatomical data of 
Rowlatt. A nomogram for use in deriving the z value of the tricuspid valve diameter from the 
echocardiographically determined diameter and body surface area published by Hanley et al. (1993) 
37
 is reproduced in Figure 10. 
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Patients with a three-portion right ventricle, whose tricuspid valve diameter is within three standard 
deviations of mean normal or whose z value of the tricuspid valve diameter is −1.5 or more, will 
have valvotomy either by interventional cardiological procedure or by surgery. The majority of 
these patients will not require a systemic-to pulmonary artery shunt. If there is infundibular stenosis 
in addition to the valvar obstruction, the patient should receive a trans-annular patch, placed using 
cardiopulmonary bypass. The patent foramen ovale is usually left open. By and large, in patients 
with a patent infundibulum whose tricuspid valve diameter is below the 99% (Figure 10). 
Confidence limit of mean normal, there is infundibular stenosis in addition to the valvar atresia. 
These patients are best treated with a trans-annular patch without closure of the patent foramen 
ovale and with a concomitant systemic-to-pulmonary-artery shunt. In Hanley’s protocol, this 
applies to patients in whom the z value of the tricuspid valve diameter is between −1.5 and −4. In 
patients without a patent infundibulum or those with a tricuspid diameter that has a z value of −4 or 
less, and those with significant anomalous coronary connections, a systemic-to-pulmonary artery 
shunt only is performed. A balloon atrial septostomy should be carried out in these patients if the 
atrial septal defect is restrictive.  
In terms of timing of intervention, patients with right ventricular outflow tract obstruction 
and intact ventricular septum fall into one of the three categories: 
1• The symptomatic neonate, who by and large will receive a palliative treatment. 
2 • The child who survived palliation in infancy. 
3.• The asymptomatic child with pulmonary stenosis. 
Symptomatic Neonate with Critical Pulmonary Stenosis or Pulmonary Atresia Cyanosis is usually 
present in such infants on the first day of life and rapidly becomes more severe as the ductus 
arteriosus closes. The suspected diagnosis of critical pulmonary stenosis or pulmonary atresia with 
intact ventricular septum is easily confirmed non-invasively by 2D echocardiography. In some 
cases, the diagnosis may already have been made prenatally.
39
  Echocardiography must provide the 
following information: size and type of right ventricular cavity; level of atresia (valvar or 
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infundibular and valvar); size and competence of the tricuspid valve; size and confluence of the 
pulmonary arteries; size of the interatrial communication; size of the patent ductus arteriosus; and 
left ventricular size and function. Cardiac catheterization and angiography are indicated when right 
ventricular sinusoidal coronary artery connections are suspected. A right ventricular angiogram will 
disclose connections between the right ventricular myocardial sinusoids and the coronary arteries. If 
there is retrograde opacification of the aortic root, there is certainly proximal continuity between the 
aorta and the coronary arteries. When dense opacifications of the coronary circulation from the right 
ventricle do not lead to visualization of the aortic root, it is necessary to exclude proximal 
discontinuity between the aorta and the coronary arteries.
31 
 
 A left ventriculography or aortogram is then necessary to study the origin of the coronary arteries 
and to identify stenosis of the coronary branches linked to the sinusoids. The primary goal of 
treatment is to maintain an adequate pulmonary blood flow. This ensures survival beyond the 
neonatal period. In addition, treatment should aim to enable the right ventricle to serve the 
pulmonary circulation whenever possible, to enlarge a restrictive atrial septal defect, to decompress 
a hypertensive right ventricle, even if not large enough to serve the pulmonary circulation, and to 
deal with coronary anomalies if present. 
Our current management protocol for neonates with pulmonary atresia and intact ventricular septum 
is as follows. Prostaglandin E is started, to maintain patency of the ductus arteriosus, as soon as the 
diagnosis is suspected. For patients with the smallest right ventricles, whose cavity is made of an 
inlet portion only, a right-modified Blalock–Taussig shunt is our procedure of choice. In patients 
with a patent infundibulum, relief of right ventricular outflow obstruction can be accomplished 
using a variety of procedures. In many centers, including our own, percutaneous pulmonary balloon 
valvuloplasty has replaced open valvotomy for most patients. Using mechanical, laser or 
radiofrequency energy, the valve is perforated and then dilated with a balloon. Pulmonary 
regurgitation introduced by the balloon dilatation is generally mild, is usually well tolerated and 
does not appear to be more severe than that introduced by surgical valvotomy. The prostaglandin 
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infusion is slowly reduced after the procedure and discontinued over the following few days. 
Surgical intervention may occasionally still be necessary for severely dysplastic valves that cannot 
be opened by balloon valvuloplasty. Surgical resection of the valve cusps with/without trans-
annular patching may then be required. Under these circumstances the procedure is usually 
performed via median sternotomy on cardiopulmonary bypass.  
Because postoperative right ventricular performance is not easy to predict, it may be difficult to 
know whether the patent ductus arteriosus and the atrial septal defect should be left patent or closed 
at the time of the operation. An outflow tract patch inevitably creates pulmonary regurgitation that 
interferes with right ventricular diastolic function. It may increase the right to- left shunt at atrial 
level, if the atrial septal defect is left open or causes congestive right ventricular failure, if it is 
closed. Occasionally, if cardiopulmonary bypass is contraindicated, closed surgical pulmonary 
valvotomy can be performed. The necessity and the timing of a systemic-to-PA shunt remains 
controversial in patients presenting with mild to moderate RV hypoplasia and a patent 
 infundibulum . 
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A smaller tricuspid valve size was the only predictive factor for the need of systemic-to-PA shunt 
after RV decompression. Management of patients with right ventricular to coronary artery 
connection remains difficult. Discrete fistulae can sometimes be ligated. Right ventricular thrombo 
exclusion was advocated 
41
 in patients with intramural connections, to prevent a steal phenomenon 
into the right ventricle. Patients with right ventricular-dependent coronary circulation might be 
inoperable and considered for heart transplantation.  
Definitive Repair of Patients with Pulmonary Atresia with Intact Ventricular Septum: 
The main strategies for definitive surgery are:
27 
1• Biventricular repair in patients with two adequate ventricles. 
2• Single ventricle repair for very small right ventricle and/or right ventricle-dependent coronary 
circulation. 
3 • One-and-a-half ventricle for varying degrees of RV hypoplasia. 
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4 • Transplantation in very high-risk patients for the above strategies. 
Study of de Leval et al., (1985) 
36
 have suggested that a three-portion right ventricle with a tricuspid 
valve diameter above the lower 99% confidence limit can safely be used to support the pulmonary 
circulation. This would also apply to patients whose z value of the tricuspid valve diameter is −1.5 
or more. Patients who fulfil these criteria, either since birth or as a result of a satisfactory 
decompression, will undergo radical repair, leading to a biventricular circulation. The operation 
consists of relieving any residual right ventricular outflow tract obstruction and closing the atrial 
septal defect and the extracardiac shunt, if present. Some or all of these procedures can be 
sometimes carried out by interventional cardiac catheterization. Recruitment of the right ventricular 
cavity by excision of hypertrophic muscle of both the trabecular and infundibular portions may 
render some ventricles suitable for biventricular repair. 
42
 An outflow tract patch enlargement or 
homograft valve placement may be necessary in some patients. If tricuspid valve regurgitation is 
present, repair of the tricuspid valve is undertaken.  
Patients whose decompressed right ventricle has not grown sufficiently to provide a right 
ventricular dependent pulmonary circulation can benefit from a variety of procedures. If it is 
believed that the right ventricular cavity is large enough to deal with two thirds of the systemic 
venous return, the superior vena cava can be connected to the right pulmonary artery (classical 
Glenn procedure), and the inferior vena caval blood can be diverted to the left pulmonary artery via 
the right ventricle, following complete relief of any residual right ventricular outflow tract 
obstruction. The atrial septal defect should ideally be closed to separate completely the systemic 
and the pulmonary circulations. 
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Figure 11. (J. Stark and V. T. Tsang.): A- one and a half ventricle repair with classical Glenn procedure; B- one 
and a half ventricle repair with bidirectional Glenn procedure. 
Because of the known complications,  classical Glenn procedure is not advisable. 
An alternative approach for the creation of a one and- a-half ventricle circulation, suggested by 
Billingsley et al. (1989) 
1
, consists of performing a bidirectional cavopulmonary anastomosis, 
inserting a homograft in the right ventricular outflow tract, and closing the atrial septal defect 
(Figure 11).  
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Fig. 12: (J. Stark and V. T. Tsang.): A- one and a half ventricle repair. 
The ASD can also be left partially opened, with a small defect created centrally in the patch so that 
at a later date closure with a device would be possible. Alternatively, an adjustable atrial septal 
defect can be used 
43
 (Figure 12). The theoretical concern about one-and-a-half ventricle repair is 
that in ventricular systole the peak pulmonary arterial pressure can be higher than the superior vena 
caval pressure, thus producing systemic venous hypertension with retrograde flow in the superior 
vena cava. Incorporating too small a right ventricle in the circulation can become more of a 
hindrance than a benefit, and a Fontan type of procedure might be preferable. 
Repair of Right Ventricular Outflow Tract Obstructions in Children 
There is no unanimity concerning the level of right ventricular systolic pressure at which relief of 
right ventricular outflow obstruction is indicated. In general, pulmonary stenosis is well tolerated 
and the risk of sudden death is much lower than with obstruction to the left ventricular outflow. A 
cooperative study 
44
 recommended surgery in children with gradients greater than 50 mmHg. The 
advent of trans-catheter balloon valvuloplasty 
45  
has reduced considerably the number of patients 
who require surgical treatment for isolated pulmonary valve stenosis. For balloon valvuloplasty, the 
combination of right ventricular hypertrophy and a peak velocity of 4m/s would encourage most 
cardiologists in the UK to intervene.
46 
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RIGHT VENTRICLE HYPOPLASIA AND ONE AND A HALF VENTRICLE 
REPAIR 
After experiments on the direct connection of the systemic venous circulation into the pulmonary 
arterial circulation, Glenn 
47
 demonstrated the clinical use of a superior vena cava (SVC)-right 
pulmonary artery (PA) shunt in 1958. Since then, a number of different cavopulmonary shunt for 
palliation of the cynotic heart diseases have been reported. Also in 1971 Fontan described 
cavopulmonary circulation as a surgical treatment for tricuspid atresia.
48
 However these techniques 
facing so many postoperative problems and surgeons world widely modifying the techniques of the 
Glenn and Fontan. Patients after cavopulmonary shunts may have many complications 
49, 50
 like: 
pleural effusions, thromboembolism, arrhythmias, protein-losing enteropathy, plastic bronchitis, 
pancreatitis, liver cirrhosis, nephropathy with microalbuminuria, neurocognitive deficits, 
arteriovenous malformations and collaterals, reduced heart rate variability, endothelial dysfunction. 
Many of these complications are related with hypertension in inferior vena cava(IVC). 
As continuation of the modification in cavapulmonary shunts, Billingsly et al. In 1989 
1
 published 
the purpose of the so called “ one and one half ventricular repair”  to achieve a physiological 
correction by separating the pulmonary circulation from the systemic one, maintaining a pulsatile 
blood flow in the pulmonary arteries. It was obtained by unloading the insufficient right 
ventricle(RV). Blood from the SVC was diverted directly to the pulmonery artery as bidirectional 
cavapulmonary shunt (BCPS) and blood from the inferior vena cava (IVC) was pumped by 30% 
unloaded RV to the pulmonary artery.
51
 
The main goal of the “one and one half ventricular repair” is to maintain a low pressure in the IVC 
district minimizing the complications related with IVC hypertension after Fontan procedure.
52
 
Theoretically, participation of the hypoplastic right ventricle in the pulmonary circulation can also 
restore ventriculoarterial coupling.  
48 
 
G. Stellin and colleagues 
51,52
 published their study about one and one half ventricle repair and 
described pulsatile pulmonary blood flow is more physiological than a continuous one, it maintains 
a low right atrial pressure and improves the systemic oxygen saturation. 
Likewise, Shio Kim and colleagues described in their 38 years follow up study, in patient with SVC 
to PA anastomosis no clinically evident protein losing enteropathy or pulmonary arteriovenous 
fistula were identified among late survivors. 
5
 The one and one-half ventricle repair recruits the 
hypoplastic right ventricle, presumably providing kinetic energy and pulsatility to pulmonary blood 
flow, while the bidirectional Glenn reduces the volume load of the right ventricle.
52 
 
 Therefore, as an alternative repair for right ventricle hypoplasia with complex congenital 
malformations to the complete by-pass of the right ventricle (diverting all venous return directly to 
the lung, according to the principle of Fontan), we believe that there is the possibility, where judged 
suitable, to utilize the pulsatile pumping capability of a small ventricular chamber, to maintain a 
more physiological pulsatile flow to the pulmonary vascular bed. This is obtained deviating the 
blood flow from the superior district of the body directly to the lung circulation by means of a 
cavopulmonary anastomosis (about 1/3 of the whole cardiac output), leaving to the hypoplasic right 
ventricle the possibility to manage the venous return from the inferior district of the body (about 2/3 
of the whole cardiac output). This, in association to a complete repair of the intracardiac 
malformation, with a complete division of the systemic from pulmonary blood circulation (one and 
a half ventricle repair)  allow to obtain a bifocal source of pulmonary blood flow (the laminar one 
from the superior district and the pulsatile one from the inferior district of the body).  
The working hypothesis 
53,54
 for a one and a half ventricle repair has been that the benefits of a 
pulsatile pulmonary circulation may avoid some of the late complication of the Fontan procedure by 
maintaining a low pressure in the IVC district and those benefits outweigh the downside risk of 
having a pulsatile flow in the SVC district.  
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Palliative surgeries for right ventricle hypoplasia 
A. Fontan procedure  
Fontan procedure is a palliative surgical procedure used in children with complex congenital heart 
defects. It involves diverting the venous blood from the right atrium to the pulmonary arteries 
without passing through the morphologic right ventricle. It was initially described in 1971 by Dr 
Fontan and colleagues from France as a surgical treatment for tricuspid atresia. Fontan performed 
the first successful right heart bypass on a patient with tricuspid atresia in 1969.
55 
   
   
  Fig. 13                                                                                                                         Prof. F. Fontan 
 
Fig.14: Thorax 1971, F.Fontan and E. Baudet. 
 
It was designed to completely separate the systemic and pulmonary circulations and thereby to 
eliminate the systemic arterial hypoxemia and LV volume overload that are the hallmarks of this 
condition. It was recognized at the onset, however, that the elevated systemic venous pressures 
inevitably present after the Fontan procedure necessary to propel the blood through the lungs in the 
absence of a “booster pump” on the right side of the circulation might lead to late complications in 
surgical survivors. Also, functional limitations would likely still exist in these patients, particularly 
for physical activities that required a substantial increase in cardiac output. 
51 
 
More than 40 years have passed since Fontan’s original surgical procedure, and it has undergone 
many technical modifications, an evolution that still continues, which have resulted in improved 
survival and a lower complication rate despite expanded application to high-risk patients.  
However, despite continued improvements, the incidence of postoperative pleural effusions remains 
high and is a key determinant of postoperative length-of-stay. 
56 - 60
 Prolonged peri-operative course 
has been associated with the late development of protein-losing enteropathy and with decreased 
long-term survival, suggesting that improvements in peri-operative course might have both short- 
and long term benefits.
60
 Factors previously shown to influence peri-operative morbidity and 
mortality include: anatomy, atrioventricular valve regurgitation, ventricular function, pulmonary 
artery pressure (PAP), support times, modified ultrafiltration (MUF), and Fontan type. 
61-65
 The 
experience of Fontan procedure for more than 4 decades with different modifications, these days 
majority of the pediatric cardiac surgeons  considers stage approach in Fontan completion. Staged 
approach in Fontan surgery with recent modification like extracadiac conduit techniques and 
fenestration demonstrated good short and midterm outcomes. 
66
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Staged approach in Fontan palliation 
Hemi- Fontan or bidirectional Glenn procedure 
 
 
Fig:15. Hemi- Fontan or bidirectional Glenn procedure 
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Surgical technique  
After full median sternotomy the superior vena cava is fully mobilized. Attention must be paid to 
the right phrenic nerve during dissection. The azygos vein is ligated or divided between ligatures to 
prevent a run-off from the higher pressure SVC to the lower-pressure IVC. If there is interruption of 
the IVC with azygos continuation, the azygos vein must be kept patent. The main and right 
pulmonary arteries are then dissected free from the surrounding tissues. If present, the shunt is also 
dissected and closed through the posterior pericardium after cardiopulmonary bypass has been 
established. It is useful to place marking sutures on the SVC and right pulmonary artery before 
bypass, because after the vessels have been divided it may be difficult to re-establish their normal 
alignment, and twisting or kinking of the anastomosis may occur. 
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 The aortic cannulation purse-string suture is placed as usual. One purse-string suture is placed on 
the right atrial appendage, and a second on the SVC near the innominate vein. The aorta is 
cannulated after full heparinization. A cannula is introduced into the right atrium through the right 
atrial appendage. Cardiopulmonary bypass is initiated, and the SVC is cannulated with a right 
angled venous cannula. The operation is performed on the beating heart with mild hypothermia. 
The cavopulmonary anastomosis is then carried out with a running suture of 6-0 prolene, which is 
interrupted in two areas to avoid a purse-string effect of the suture line and to maintain a wide 
anastomosis. The patient is rewarmed, and the bypass is discontinued. Additional sources of blood 
supply, such as the forward flow across a stenosed pulmonary outflow tract or a left systemico-
pulmonary artery shunt, are usually left patent to maintain higher systemic oxygen saturations. In 
the case of bilateral superior vena cava, it is necessary to do a bilateral bidirectional cavopulmonary 
anastomosis, unless there is a large bridging vein and one of the two cavae is small. Both cavae 
must be cannulated separately. The hemi-azygos vein is ligated unless there is hemi-azygos 
continuation of the IVC, and the left cavopulmonary anastomosis is constructed as described above 
for the right side. Some surgeons prefer to avoid direct cannulation of the SVC, particularly if the 
vessel is small, and to perform the cavopulmonary anastomosis during deep hypothermic 
circulatory arrest. Another technique for the construction of a superior cavopulmonary anastomosis 
is the use of a temporary shunt between the superior vena cava and the right atrium, thus avoiding 
the use of cardiopulmonary bypass and its deleterious effects. 
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Fonatn: Lateral tunnel or intra-cardiac tunnel technique 
 
Fig:16. Fonatn: Lateral tunnel or intra-cardiac tunnel technique 
67
  
Surgical technique  
A bidirectional Glenn shunt may already be in place,  otherwise the beginning of this operation is 
similar to that described for bidirectional Glenn procedure using cardiopulmonary bypass. A piece 
of pericardium is harvested in case of its need as an only patch on the pulmonary artery. The SVC is 
fully mobilized, taking care not to damage the right phrenic nerve. The azygos vein is also dissected 
and may be later temporarily occluded with a bulldog clamp during the anastomosis of the SVC to 
the pulmonary artery. The main pulmonary artery and its bifurcation, the right and left branches, are 
circumferentially dissected and mobilized beyond the lateral pericardium and their branching. The 
ligamentum arteriosum is doubly ligated and divided. If present, the systemic-to-pulmonary artery 
shunts are controlled in the usual manner. A right shunt will be disconnected from the pulmonary 
artery, as described above. The ascending aorta is cannulated.  
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The cavae are cannulated with right-angled cannulae superiorly near the innominate vein and 
inferiorly at the cavoatrial junction. Cardiopulmonary bypass is initiated, and the patient is cooled to 
28–30◦C. The dissection of the pulmonary arteries and the shunts is completed if necessary. A snare 
is snugged around the SVC, or alternatively the vein is controlled with a vascular clamp placed just 
proximal to the cannula. Another vascular clamp is applied just above the SVC/atrial junction, and 
the SVC is transected. The bidirectional cavopulmonary anastomosis is then constructed on the 
beating heart, as described earlier. When the anastomosis is nearly completed, the patient is cooled 
to 28◦C. The aorta is cross-clamped, and cold cardioplegic solution is infused. 
A needle vent is placed in the ascending aorta. The main pulmonary artery is transected. To prevent 
bleeding and aneurysm formation, the proximal stump is closed with a double row of continuous 5-
0 polypropylene suture, reinforced with two small Teflon felt strips, and the pulmonary valve 
leaflets incorporated in the suture line. If the distal main pulmonary artery is not used for the 
cavopulmonary connection, it is closed with a patch, so as not to narrow or distort the branch 
pulmonary arteries. The right atrium is then opened. The atrial septal defect is left open or is 
sometimes enlarged when the left atrio-ventricular valve is atretic or stenotic, to allow the 
pulmonary venous return to reach the right atrio-ventricular valve in an unobstructed fashion. 
The intra-atrial cavo-caval pathway may consist of the interposition of a conduit of 
polytetrafluoroethylene (Gore-Tex) between the caval orifices, or the creation of a composite 
conduit made of the lateral atrial wall and a prosthetic patch, or the construction of an atrial baffle, 
establishing the continuity between the IVC and SVC.  
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Conduit insertion. 
 The right atrium is opened along the crest of the appendage. The bypass flow is reduced to quarter 
flow. The IVC cannula is clamped and removed and the IVC snare released. A sump sucker is 
placed into the IVC through the purse-string suture of the cannulation site . This allows good 
visualization of the IVC orifice from within the right atrium. The length of the atrial conduit is 
measured between the Eustachian valve and the crista terminalis. The conduit should be as short as 
possible. A Gore-Tex prosthesis of at least 18mm is then sewn in the IVC at its junction with the 
right atrium, with a running suture of 4-0 or 5-0 polypropylene. The conduit is then trimmed 
obliquely and shortened, to be sewn on the prominent ridge made by the crista terminalis in front of 
the SVC.  The right atriotomy is then closed with a running 5-0 Prolene suture.  
 
 
Fig:17- Conduit insertion in lateral tunnel technique 
27
 . SVC- superior vena cava; IVC- inferior vena cava; FO – 
fossa ovalis; CS – coronary sinus; AC- after completion of the lateral tunnel technique repair. 
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 When a lateral tunnel is created, a Gore-Tex conduit of at least 16mm in diameter is sized as before 
and split longitudinally. The baffle is sewn halfway around the junction of the IVC with the right 
atrium, along the posterior atrial wall, crista terminalis and half-way around the junction with the 
SVC. Care is taken to avoid the sinus node. The right atriotomy incision is then closed with a 
running suture of 5-0 polypropylene. The rest of the operation is identical in all cases. The IVC 
cannula is replaced, and the perfusion flow is increased. 
 The distal opening of the main pulmonary artery is enlarged, making an incision toward the right 
pulmonary artery. Alternatively, the anastomosis can be made on the undersurface of the right 
pulmonary artery only. At initial period of our experience, we used to make an incision on the 
medial aspect of the SVC to enlarge it to the diameter of the IVC. This does not deal with the 
restriction produced by the crista terminalis within the right atrium. If this incision was carried out 
into the right atrial chamber, there would be a risk of damaging the sinus node artery in a significant 
proportion of patients. We do not enlarge the cardiac end of the SVC. The anastomosis between the 
cardiac end of the SVC and the pulmonary artery is done with a running suture of 5-0 or 6-0 
polypropylene. The suturing starts with the right pulmonary artery, taking wider bites on the 
pulmonary artery than on the SVC, so as to make up for the discrepancy in the diameter of the two 
structures. Usually, this anastomosis can be made without a patch. However, it is sometimes 
necessary to use a small pericardial patch medially . It is a mistake to simply anastomose the 
transected main pulmonary artery and the transected SVC, as this distorts the pulmonary artery, 
which has to be brought right-ward and anteriorly. The patient is fully rewarmed, and air is 
evacuated from the heart. It is particularly important to aspirate the air from that portion of the right 
atrium that is now part of the systemic circulation. A left atrial line is inserted into the right upper 
pulmonary vein or directly into the left atrium before cardiopulmonary bypass is discontinued. In 
patients who have had a prior hemi-Fontan operation, the beginning of the operation proceeds in the 
same way. Following opening of the right atrium the previously patched SVC orifice is opened. 
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Placement of the intra-atrial tunnel to complete the total cavopulmonary connection then proceeds 
as described above. 
Extra-cardiac or external  tunnel technique with fenestration 
 
 
                                      
Fig: 18. Fonatn: Extra-cardiac or external  tunnel technique with fenestration
27:  
SVC- superior vena cava; RPA- 
right pulmonary artery, Ao- aorta, ext. cond.- external conduit, fenest.- fenestration. 
 
Surgical technique 
In selected patients the operation can be performed without exposing the patient to the damaging 
effects of cardiopulmonary bypass. 
68
 In patients without a prior SVC-to-pulmonary artery 
connection, this is performed using a temporary shunt from the SVC to the right atrium. For 
completion of the extracardiac total cavopulmonary connection (TCPC), the anastomosis between 
the conduit and undersurface of the pulmonary artery is performed. Next segment of the central 
pulmonary arteries is isolated by placing two clamps. One is from the medial aspect of the 
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cavopulmonary shunt obliquely across the right pulmonary artery, thus diverting blood flow from 
the shunt to the right lung only; care has to be taken not to obstruct the shunt flow, which is 
necessary to provide systemic oxygenation. The other clamp is placed across the left pulmonary 
artery. 
Following completion of the anastomosis, the clamps are replaced with a single clamp half-way on 
the conduit and bidirectional cavopulmonary shunt is re-opened. Decompression of the IVC for the 
distal anastomosis is achieved by constructing a temporary right atrial-to-IVC shunt, by connecting 
two venous cannulae together. 
ADDITIONAL PROCEDURES 
Fenestration of the Intra-atrial Baffle 
Early mortality after the Fontan procedure can be related to a transient haemodynamic disturbance, 
such as a postoperative increase in the pulmonary vascular resistance or systemic ventricular 
dysfunction. Whatever the cause of the failure, systemic venous hypertension is a common 
denominator that in itself may be responsible for a vicious circle. It causes capillary leakage in the 
interstitial compartment and in the peritoneal, the pleural, and sometimes the pericardial cavities. 
Systemic venous hypertension is also responsible for hypertension in the lymphatic system, 
including the lungs, which may become congested, with further increase in the pulmonary vascular 
resistance. Immediately after a Fontan procedure, there is usually a reduction in the end-diastolic  
volume, with significant increase in ventricular wall thickness and stiffness.
69   
This is in the presence of inflow restriction to the left ventricle resulting from the increased 
pulmonary vascular resistance, another step in the vicious circle. An ingenious and elegant method 
to prevent this vicious circle was simultaneously developed by the Boston group 
70 
and the Los 
Angeles group 
71
 for patients at increased risk. The technique consists of fenestrating the atrial 
baffle or conduit or making an adjustable atrial septal defect. Right-to-left shunting through this 
defect allows the cardiac output to be maintained at the expense of some arterial desaturation and 
prevents undue elevation of the systemic venous pressure. The size of the interatrial communication 
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can be calculated from the Gorlin formula. If one-third of the systemic venous return is diverted to 
the left atrium, the arterial oxygen saturation will be greater than 85%, assuming a mixed venous 
oxygen saturation of 60%. For a right atrial pressure of 15mmHg and a left atrial pressure of 10 
mmHg, and if one-third of the venous return traverses the atrial communication, a defect of 6 
mm/m2 is required. In practice, a defect of 4–6mm in diameter unloads the systemic venous 
circulation while the systemic arterial saturation remains around 85%. 
 In patients with an intra-atrial baffle, a fenestration is made in the Gore-Tex conduit with a 4–6mm 
punch. The adjustable atrial septal defect is rarely used any more. If an extracardiac conduit has 
been used, a 4–6mm hole is cut in the Gore-Tex tube and a slightly larger hole in the opposite free 
atrial wall. To avoid obstruction of the fenestration by atrial tissue, the atrial wall is anastomosed to 
the Gore-Tex tube a few millimeters away from the margin of hole in the prosthesis. In a high 
percentage of cases, the fenestration can be subsequently closed using a trans-catheter technique. In 
their early experience, Bridges et al 
70
 were able to close the fenestration in 11 of 19 patients within 
20 days of surgery. A test occlusion is first carried out. A rapid fall in the right atrial saturation with 
test occlusion is an indication to leave the fenestration open. In some of their cases, failure to 
tolerate test occlusion was attributed to residual distal pulmonary stenosis, which were relieved by 
transcatheter dilatation; to aortopulmonary collaterals, which were embolized; or to systemic 
ventricular dysfunction, which improved with time and medical management. We have also adopted 
this technique of baffle fenestration for high-risk patients. This includes patients who had 
undergone banding of the pulmonary artery and patients with borderline pulmonary vascular 
resistance and/or systemic ventricular dysfunction.  
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Recent development of Fontan procedure 
After a successful Fontan operation, their physical performance is most often improved. However, 
Fontan et al. mentioned in 1990, that the encouraging initial early postoperative results should be 
re-evaluated for long-term morbidity 
72
. Modifications of the Fontan procedure and staging with 
bidirectional cavopulmonary shunt have extended the indications for this operation to a wide range 
of congenital heart defects unsuitable for biventricular repair 
73
. 
In spite of significant improvement in outcomes, most of the congenital heart departments  
managing patients with complex congenital heart disease report contemporary mortality rates 
associated with the Fontan operation up to 7%. 
74
 Perioperative mortality has been attributed to 
ventricular dysfunction, stroke, thromboembolism, and multi-organ dysfunction. Numerous 
investigators have sought to identify patient factors and procedural factors associated with increased 
risk of mortality .
75
 In patients with hypoplastic right ventricle or with borderline right ventricle one 
and a half ventricle repair is considerable as an alternative to Fontan procedure. 
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B. ONE AND A HALF VENTRICLE REPAIR  
 
FIG:19. (FROM smilenaire.com, GOOGLE): Q-flow, SVC- superior vena cava, AZG- azygos vein, RPA- right 
pulmonary artery, LPA- left pulmonary artery, MPA- main pulmonary artery, RV- right ventricle, LV- left 
ventricle, LPV- left pulmonary vein, RPV- right pulmonary vein, PA- pulmonary artery, Half Ventricle- right 
ventricle which receives only half  of the venous blood of the body which comes from inferior vena cava, blood 
from superior vena cava goes directly to the RPA. One ventricle means- full or ventricle which receives whole 
arterial blood; by this way creates the  one and a half ventricle. 
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Fig.20: so called “Half ventricle” alone: SVC- superior vena cava, RA- right atrium, IVC- inferior vena cava, 
RV- right ventricle, MPA- main pulmonary artery: arrow indicates the blood flow.  
 
The one and half ventricle repair consists of a superior cavopulmonary anastomosis combined with 
the connection of the dysfunctional right ventricle to the pulmonary artery through either a right 
ventricle outlet tract (RVOT) with the closure of the atrial septal defect in order to allow for 
desaturated inferior vena cava blood to enter the dysfunctional ventricle and flow to the pulmonary 
arteries or just  direct connection of the SVC to right pulmonary artery and allowing flow of the 
blood coming from IVC to main pulmonary artery through hypoplastic right ventricle. 
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The one and a half ventricle repair can be considered the last stage of the functional single ventricle 
pathway, in that the systemic and pulmonary circulations are entirely separated, and there is no 
compelling reason to perform a more traditional Fontan operation. A fenestrated one and a half 
ventricle repair can be performed in patients with significant risk factors, and consists of a superior 
cavopulmonary anastomosis with connection of the dysfunctional ventricle to the pulmonary 
arteries, along with a 4-5 mm snared fenestration in the atrial septum. 
Since the original contributions of Billingsley et al 
1
 to the one and a half ventricle concept in 
patients with hypoplastic right ventricle, the indications for this type of repair have expanded to 
cover a variety of anomalies that feature a functionally abnormal right ventricle that would not be 
able to cope with the entire pulmonary circulation. 
In recent years, the tendency has been to submit such patients to the so-called "one and a half 
ventricle repair". In this procedure, the heart is surgically septated. This might include one or more 
of the following intra-cardiac procedures: atrial septal defect closure, ventricular septal defect 
closure, atrioventricular canal repair and removal of the Rastelli type left ventricular - aortic valve 
baffle and the right ventricular - pulmonary artery conduit, thus, creating a superior cavopulmonary 
shunt. The later component of the procedure eliminates all systemic-pulmonary mixing and 
provides preload reduction for the limited right heart, thereby, avoiding right heart failure. 
Patient selection for the one and a half ventricle repair comes under consideration in two specific 
clinical border zones. In one, the patient is a borderline candidate for the two ventricle repair, and 
the surgeon "backs off" to the one and a half ventricle repair to avoid postoperative right heart 
failure. Examples might include the patient with pulmonary atresia and intact ventricular septum 
with a right ventricle that is reasonably well developed but demonstrates morphological and/or 
physiological characteristics. At the other clinical border zone, the patient is clearly not a candidate 
for the two ventricle repair, and the focus over the course of the patient's life has been toward 
achieving a Fontan operation; however, the internal morphology of the heart does allow a surgical 
septation. 
76-80 
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ORIGINAL STUDY 
1. Aim of the study  
a. Clinical part 
          To analyze short term and long term outcomes of the patients who operated  
         by one and a half ventricle repair technique at our institution. 
b. Animal model  
1. To evaluate the competition of flows at the superior vena cava – right pulmonary artery 
junction, to understand the hemodynamic interaction of a pulsatile flow in combination to a 
laminar one. 
2.  To evaluate the effects of venous hypertension on the superior vena cava districts by 
evaluating the oxygen saturation. 
3. To evaluate the advantages of bifocal pulmonary blood flow (mixed laminar and pulsatile) 
on pulmonary microvascular circulation in comparison to a whole laminar pulmonary blood 
flow (Fontan repair).  
4. Evaluation of the advantages of the 1.5 ventricle repair on maintaining low pressure in the 
inferior vena cava district. 
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2. MATERIAL AND METHODS 
a. Clinical study 
      We retrospectively analyzed our institutional database and reviewed the entire experience with 
1.5 VR of congenital heart defects between March 1994 and January 2012. Patients’ characteristics 
are shown in table 2 and diagnosis leading to surgery  shown in table 3. 
All available clinical and operative data were reviewed. Review of medical records was approved 
by hospital local committee on clinical investigation. All patients were studied preoperatively by 
means of a two-dimensional (2D) – echocardiography and Doppler, in order to evaluate TV and RV 
dimensions and RV function. TV assessment was made by obtaining the larger annulus diameter 
measured from a standard 2D – Echocardiography apical four chamber view, this was indexed for 
body surface area and then compared to normal values for body surface area. Cardiac 
catheterisation was also performed in all, before repair, to assess cardiac pressures and calculate 
pulmonary vascular resistances (PVR). The preoperative cardiac rhythm was established for all 
patients by EKG; other clinical data gathered at admission included: venous blood oxygen 
saturation (SatO2), presence and degree of cyanosis, medical therapy. Any early postoperative 
adverse events were registered and all patients received a 2D-Echocardiography qualitative 
evaluation of right and left ventricle contractility; we also evaluated drugs administrated and cardiac 
rhythm at discharge. Follow-up was completed and updated in all, with a mean of 5.7 years (range 
0.2 – 12 years). All the patients were followed with clinical evaluations and 2D-ecocardiography 
and Doppler. Exercise stress test at cicloergometer was performed in one patient with Ebstein’s 
anomaly. 
Patients were divided in: Group A - patients with right ventricle hypoplasia/dysfunction and 
malformations of  tricuspid or pulmonary valves; Group B - patients with associated complex 
malformations involving other cardiac structures. 
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Table: 2.  Patients’ Characteristics  
 Total Simple(groupA) Complex(groupB) 
Pt. NO 24 14 10 
Sex(M/F) 12/12 10/4 2/8 
Weight 5.6-83 kg 5.6-83kg 6.8-18.6 kg 
Age 4m.-66.8 5m-66.8yr 7 m-8 yrs 
 
Table: 3. Diagnosis leading to surgery 
Group A(Simple)                                                                group B (Complex) 
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1. Statistical analysis 
          Overall survival at 18 years for all patients is 85%. Survival is evaluated according to 
different variables. Survival estimate is 90% at 18 years for group A and 75 % for group B p 
value = 0.96(Figure 34). Overall freedom from adverse events, surgery and interventional 
procedures was 56.5 %, 87 % and 73,9 % respectively. Freedom from adverse event in 
Group A (n=12) was 83.3 % while in Group B (n=11) was 27.3 %. Statistical analysis 
demonstrated that Group B had a significantly lower freedom from adverse events than 
Group A (p = 0.015). Overall survival were estimated by the Kaplan-Meier method (figures 
34-35). Log-rank test was used for comparisons between groups. Statistical findings were 
considered significant if the critical level was less than 5% (P-value < 0.05). Statistical 
analysis was performed using STATA software (Release 10.0 for Windows, StataCorp LP). 
Preoperative assessment 
All patients were studied preoperatively by means of a two-dimensional (2D)  
echocardiography and Doppler, in order to evaluate TV and RV dimensions and RV 
function. TV assessment was made by obtaining the larger annulus diameter measured from 
a standard 2D – Echocardiography apical four chamber view, this was indexed for body 
surface area and then compared to normal values. Cardiac catheterisation was also 
performed in all, before repair, to assess cardiac pressures and calculate pulmonary vascular 
resistances (PVR). The preoperative cardiac rhythm was established for all patients by EKG; 
other clinical data gathered at admission included: venous blood oxygen saturation (SatO2), 
presence and degree of cyanosis, medical therapy. 
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2. Surgical technique 
One and a half ventricle repair was performed by the same surgeon in all patients. Surgical 
repair was carried out through a midline stenortomy (redo in two patients), superior and 
inferior vena cava (SVC and IVC) were cannulated directly (SVC next to the origin of the 
left innominate vein). Mild hypotermic (rectal temperature between 28 and 34 ° C) cardio-
pulmonary bypass was instituted in all. Aortic cross-clamping and multiple doses of 
haematic cardioplegia was employed in all.TV annulus diameters were sized with Hegar’s 
dilators confirming the preoperative echocardiographic values. The three patients with 
Ebstein’s Anomaly showed a various degree of downward dislocation of posterior and septal 
leaflets and tethering of the anterior leaflet to the RV free wall; all had serious limited 
functional RV, due to a large atrialized portion. Two of them required TV surgery: one TV 
repair (Vargas procedure20) and one TV replacement (with bioprosthetic valve Carpentier-
Edwards no. 25), this later patient underwent additional annuloplasty of incompetent mitral 
valve (performed through the ASD II). The remaining two patients presented TV and RV 
hypoplasia at inspection, one of them required right ventricle – pulmonary artery continuity 
reconstruction with conduit Contegra no. 16 for pulmonary valve stenosis. Additional  
procedure were: PFO/ASD II closure, n=4; radiofrequency ablation (RFA) of the IVC sinus, 
n=1; RFA – Mazè procedure with atrioplasty n=1, this latter patient also had definitive pace-
maker implantation. 
     All patients received end-to-side anastomosis between SVC and right pulmonary artery 
    brunch (BCPS) at beating heart; the azygos vein was ligated in two patients. 
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3. Postoperative assessment and follow-up 
  Any early postoperative adverse events were registered and all patients received a 2D-  
 Echocardiography qualitative evaluation of right and left ventricle contractility; we  
 also evaluated drugs administrated and cardiac rhythm at discharge. There were no operative 
death. Mean ICU stay 6 ± 7 d, median 3 d (range1-29 days). Mean hospital stay : 32± 29 days, 
media 23 (6-113 days). Among in hospital complications 18 patients had different types of 
complications like: Pleural effusions in 8 patients, Chylothorx/pericardium in 7, different 
arrhythmias in 7 patients, acute renal failure 4, Postoperative low cardiac output in 4, Pericardial 
effusion in 3, Superior vena cava syndrome in 2, complete A-V block in 1,Hemidiafragm 
paralisys in 1 and pulmonary infection was diagnosed in 1 patient. 
Follow-up  
Follow up was completed and updated in all, with a mean of 5.7 years (range 0.2 12 years). All 
the patients were followed with clinical evaluations and 2D-ecocardiography and Doppler. 
Exercise stress test at cycloergometry was performed in one patient with Ebstein’s Anomaly. 
Follow up time range 6 months-18 years; mean follow up time is  8.3 years. 
Follow up 96% completed 23/24 pts, 1 foreigner patients lost at follow up. At early follow up 7 
patients had different 11 complications as shown in table 4. 
Table: 4. Early complications 
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Among survivors(22) 19 patients are in NYHA class I. Eleven patients among24( 46%) had late 
complications. Late complications shown in table 5. 
Table: 5. Late complications 
 
During follow up 2 patients died: one patients died during redo surgery; aortic valve replace 
ment+ RV-PA conduit and left pulmonary artery plasty and immidietely after surgery patients 
assisted by ECMO and died after few hours of surgery. Another late death non cardiac related, 
patient with Ebstain’s anomaly died due to stroke 2 years after 1.5 ventricle repair. 
Three patients had late reoperation: 
1. RVOT revision + 2-ventricle-conversion” 
2. Subaortic fibrous tissue resection + re-do tunnel IVC to left sided atrium+ Contegra conduit 
change + RPA enlargement. 
3. AVR + RVPA conduit +LPA plasty, ECMO 
At late follow up 6 patients had 15 different interventional procedures, shown in table 6. 
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             Table: 6. Transcatheter procedures late after 1.5 ventricle repair  
Type of procedure No. 
LPA dilation/stenting 4 
MPA dilatation 3 
IVC-LA baffle balloon dilatation/                 
stent 
     3 
RVOT diltation attempts 2 
Stent SVC 1  
device ASD closure      1 
Azygous vein plugging 1 
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b. ANIMAL STUDY 
MATERIAL AND METHODS 
This experiment was performed in experimental Rabbits. Animal care has taken according to 
established standard for experiment in animals.  
Experimental model: RABBIT 
Strain:  NEW ZEALAND 
 
Fig.21. animal prepared for intubation 
Total animal number: 30 
 Weigh of animals: 4.5-5.5 kg 
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Experimental time period: 24 hours        
GROUPS:  
Animals were divided in three groups, hemodynamic measurements were taken from all three 
groups at resting condition and after induced pharmacological stress test with intravenous 
adrenaline bolus infusion of 0.02mcg/kg/min 
1) normal controls                                   10 
 Resting condition + after induced pharmacological stress   
2) Right BCPS (1.5 v repair)                         10  
Resting condition + after induced pharmacological stress  
3) Right BCPS  + LPA closure (CPA alone)  10 
Resting condition + after induced pharmacological stress    
SVC: superior vena cava, BCPS: bidirectional cavopulmonary shunt, RPA: right pulmonary 
artery, LPA: left pulmonary artery, 1.5 v repair: one and a half ventricle repair, CPA: 
cavopulmonary anastomosis. 
1. ANESTHESIA 
Type: general 
Anesthetic Agents 
82
 Induction:         Ketamine 4mg/kg intravenous 
    Mainteinance:       Halothane 2 litre/min, inhalation 
    Myorlaxant:     Pancuromium 0.25mcgr/kg/min, intravenous 
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2.Vital sign measurements  
 
Fig:22. Animal after having the arterial and venous accesses. A.C.- arterial cannula, V.C. – venous cannula.   
 
Fig: 23. Vital sign monitoring 
 
Vital signs were measures as in standard operating room for animal. To administer 
intravenously fluids and drugs right vein in the right auricle (ear)  was cannulated.   To measure 
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the blood pressure during and after performing the procedure artery in the left auricle was 
cnnulated  by 16 fr. IV cannula. To have the intravenous or arterial access in other part of the 
body found to be difficult. Saturation rate, heart rate, ECG monitoring also was achieved with 
the use of standard operating room monitor of SIEMENS SC 9000 as shown in fig. 23. 
3. Intubation: endotracheal  
 
Fig:24. Endo-tracheal intubation of the rabbit through tracheostomy incision  
 
Intubation has performed with direct tracheostomy incision as shown in fig.24. We have used 
pediatric endotracheal tube- uncuffed tubes of 2.5-3.5 Fr. 
82, 83
 Uncuffed tube because, to allow 
as large an internal tube diameter as possible. After intubation, endotracheal tube has fixed with 
open-weave bandage tied around the connector and then around the back of the rabbit’s head 
then connected with ventilator. 
 
 
78 
 
4.Ventilation: mechanical  
 
Fig.25. animal connected to ventilator 
Ventilator settings were as follows: 
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PEEP- 2-3 mm of water. 
Tidal volume- 7-10 ml/kg 
Respiratory rate- 20-30/min. 
We used OLMEDA Excel 210 SE mechanical ventilator, rabbit was connected to the ventilator 
through endotracheal tube and assisted by Halothane gas with rate of 2litre/min during and after 
completion of the procedure. 
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5. SURGICAL TECHNIQUE 
 
  
Fig: 26. Full animal preparation before surgery  
 
Animal was prepared according to the standard techniques for animals 
85-90
 and animal care was 
taken as recommended by the ethical committee. Two technicians, one operating nurse and 
three surgeons were involved in this procedure. Operation was performed through right lateral 
thoracotomy in general anesthesia. Duration of the procedure was around 2-3 hours for each 
rabbit. Rabbit was fully heparinized before making the anastomosis with the dose of 100 IU/kg 
of heparin. Cavapulmonary anastomosis was done without cardiopulmonary bypass.  
Anastomosis was made in end to side fashion between superior vena cava and the right 
pulmonary artery as shown in fig.30. To make this anastomosis two curve Shatinsky clamps 
were used as showen in fig.28. Monofilament polypropylene (Proline) 6.O suture were used to 
make the cavapulmonary anastomosis. After completing the anastomosis between superior vena 
cava and right pulmonary artery blood pressure were measured from superior vena cava, right 
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pulmonary artery, right atrium and right ventricle. Pressures were measured at resting condition 
and after pharmacologically induced stress test. Pharmacological stress test was performed by 
giving intravenously adrenaline bolus 0.02mcg/kg.  Rabbits were continuously monitored 
during and after surgery with standard monitoring techniques as shown in figure 23. After 
completion of the all measurements animal was sacrificed within 24 hours from surgery as 
recommended by ethical committee.  
 Surgical access: right thoracotomy 
 
Fig. 27. Right thoracotomy incision in a rabbit 
No cardiopulmonary bypass 
Partial heparinization: 100 Units/kilograms 
 
81 
 
 
Fig:28.A curve Satinsky  clamp used during surgery 
 
 
 
Fig. 29. During surgical intervention in a rabbit (OR view) 
 
 
We have divided the experimental animals in four groups for hemodynamic measurments  
Group 1: NORMAL CONTROLS 
a) pulsatile pulmonary flow 
  b) no hypertension in the SVC district 
  c) no hypertension in the IVC district 
This group is for normal control and no surgery has been done. 
 Group 2: after cavopolmonary anastomosis (CVPA) 
a) pulsatile pulmonary flow 
  b) hypertension in the SVC district  
  c) no hypertension in the IVC district 
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this group have normal pulsatile pulmonary flow from right ventricle. It has created 
hypertension in SVC district and found normal pressure as before surgery in IVC district. This 
group for evaluation of the cerebral metabolic changes due to hypertension in SVC district and 
evaluation of the blood flow distribution to the lungs.  
Group 3: after CVPA with stress test 
a) pulsatile pulmonary flow under stress 
  b) hypertension in the SVC district (BCPS + pulsatile flow) 
  c) found no Hypertension in the IVC district 
in this group excersice test was performed by infusing a bolus of adrenaline 0.08mcg/kg. 
In this group we have evaluated mixed laminar and pulsatile blood flow distribution to the lungs 
and evaluated the indirect signs of the right ventricular failure by measuring the pressure 
changes in right ventricle and right atrium immediately after giving the adrenaline infusion.  
Group 4: after CVPA and clamping of the left pulmonary artery 
a) pulsatile pulmonary flow only on LPA 
b) no anterograde flow on RPA 
  b) hypertension in the SVC district  
  c) found no hypertension in the IVC district 
 
In this group as we close the RPA there won’t be any pulsatile flow to right lung but there is 
anterograde flow to the LPA. There is no hypertension in   SVC district because there is no any 
reverse flow from RPA and found no hypertension in IVC district too. 
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6.  INTRAOPERATIVE EVALUATION 
 
Fig: 30. Intraoperative view of the cavapulmonary anastomosis in a rabbit(1.5 VR); SVC: superior vena cava, 
RPA: right pulmonary artery, CPS: cavapulmonary shunt(anastomosis between SVC and RPA), RA: right 
atrium, RV: right ventricle. 
 
Hemodynamical measurements: pressure sampling 
 (RSVC, RA, RV, MPA, RPA, LPA) 
RSVC:  right superior vena cava 
RA:  right atrium 
RV: right ventricle 
MPA: main pulmonary artery 
LPA: left pulmonary artery 
Pressure measurement has done by direct puncher to the RSVC,  RA, RV, MPA, RPA, LPA. 
POSTOPERATIVE TIME (before sacrifice): 24 hours 
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7. POSTOPERATIVE EVALUATION (before sacrifice) 
In post-operative period we have evaluated the effects of venous hypertension on the superior 
vena cava districts (brain) by evaluating the oxygen saturation.  
Likewise, we have analyzed the competition of flows at the superior vena cava, right pulmonary 
artery junction: to understand the hemodynamic interaction of a pulsatile flow in combination to 
a laminar one in postoperative period by direct puncher. 
We have observed the venous pressure in RA and RV to evaluate the advantages of the 1.5 
ventricle repair on maintaining the low pressure in the inferior vena cava district by direct 
puncher on right atrium and right ventricle. 
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c. RESULTS  
1. Results of clinical study  
This is an 18 years retrospective clinical review of 24 consecutive patients who underwent one 
and a half ventricle repair at our Institution. Mean age at repair was 11.9 years (range 4 months 
– 66.8 years). Mean TV annulus Z-score was -3.2 (range -6.2 to 3.6). Mean pulmonary vascular 
resistance was 1.75 U/m2 (range 1.0 to 3.0). Three patients had heterotaxy syndrome. Sixteen 
patients underwent previous cardiac operation, one of these had a Fontan operation. 
There was no death at operation. Postoperative complications occurred in 19 patients (79 %), 
and were: chylothorax/chylopericardio (n=7), BAV III (n=2), arrhythmias (n=7), renal failure 
(n=4), heart failure (n=4), cardiac/pleural effusion (n=11), SVC syndrome (n=2), pulmonary 
infection (n=3), hemidiaphragm paralysis that required diaphragm plasty (n=1), SVC 
thrombosis with PE (n=1). Five patients required definitive PM implantation. All patients were 
discharged home alive and well, after a mean hospital stay of 32 ± 29 days. At a mean follow up 
of 8.3 years (range 1 month – 17.9 years, FU completeness: 96 %), there were 2 late deaths (1 
non cardiac related). Among survivors, functional status was NYHA class I in 19 patients 
(90.4%). Late adverse events occurred in 10 patients (43 %) including: late reoperation (n=3), 
one of these was a biventricular conversion; haemodynamic procedures (n=6); arrhythmias 
(n=2); neurological event (n=1); other complications (n=5).  
Overall freedom from adverse events, surgery and interventional procedures was 56.5 %, 87 % 
and 73,9 % respectively. Freedom from adverse event in Group A (n=12) was 83.3 % while in 
Group B (n=11) was 27.3 %. Statistical analysis demonstrated that Group B had a significantly 
lower freedom from adverse events than Group A (p = 0.015). statistical analysis of the results 
were shown in figure 31-38. 
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Fig:31. Freedom from adverse events 
 
p = 0.015 
 
Fig:32. Freedom from re-operation 
 
 
p = 0.57 
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Fig:33. Freedom from cath. procedures 
 
 
p = 0.40 
 
Fig:34. Survival rate 
 
 
 
 
 
p = 0.96 
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Fig:35. Overall survival 
 
 
 
 
 
Fig:36. Overall freedom from adverse events 
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Fig: 37. Overall freedom from re-operation 
 
 
 
 
Fig:38. Overall freedom from cath procedure 
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     2. Results of animal Study 
This is an animal model study on one and a half ventricle repair which was performed in 
rabbits. We performed an anastomosis between superior vena cava and right pulmonary 
artery as a model of one and a half ventricle repair. After performing this cavapulmonary 
anastomosis we measured the pressures from different cardiac chambers, SVC and 
pulmonary arteries during resting condition and after induced pharmacological stress 
test. Likewise, we have created the model of cavapulmonary shunt alone by clamping 
the right pulmonary artery just proximal to the cavapulmonary anastomosis to allow the 
blood flow coming from the inferior vena cava only to the left pulmonary artery through 
right ventricle.  Results are shown in table 7-12 and figure 41-45. 
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Table:7. (A). Control group: (n. 10)  
Resting condition 
No. BP HR RA RV SVC PA 
1 72/40 90 7 14/7 6 14/7 
2 90/50 102 8 18/5 5 17/5 
3 83/40 86 6 16/4 4 16/4 
4 80/50 92 8 18/6 6 17/6 
5 94/56 76 7 15/5 6 15/7 
6 70/45 106 8 14/4 7 14/4 
7 85/42 88 9 13/5 6 13/5 
8 90/50 101 6 15/5 4 15/5 
9 78/62 105 7 17/6 5 17/7 
10 86/65 94 8 20/4 6 20/4 
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Table:8. Control group  
After induced pharmacological stress test  
  N0 BP HR RA RV SVC PA 
  1 110/90 100 8 15/6 5 15/6 
  2 115/80 116 9 16/4 6 16/5 
  3 100/76 100 7 14/3 4 15/4 
  4 100/80 110 9 15/2 7 15/3 
  5 120/80 105 8 10/2 6 11/2 
  6 116/92 120 9 12/3 8 12/4 
  7 120/80 108 10 14/6 6 14/6 
  8 110/70 110 7 13/6 5 13/6 
  9 106/92 116 8 14/4 6 15/4 
  10 112/96 118 9 14/3 6 15/4 
 
 Median SVC pressure: 1) at rest = 6 mmHg (R 4-7)  , 2) after stess: 7 mmHg  
(R 4-8)  > 10% 
  Median RA pressure: 1) at rest = 7 mmHg (R 6-9)  , 2) after stress: 8 mmHg 
(R 7-10) >11.1%  
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Fig: 39. (A) Group: Bidirectional cavapulmonary shunt 
              (BCPS) +  pulsatile RV flow (1.5 V model) (n=10)  
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Table:9. One and a half ventricle repair model (n=10) 
Resting condition 
No. BP HR RA RV SVC PA 
1 72/40 90 7 14/7 20 15/7 
2 90/50 102 8 18/5 18 18/4 
3 83/40 86 5 16/4 22 17/5 
4 80/50 92 7 18/6 18 19/6 
5 94/56 76 7 15/5 25 15/4 
6 70/45 106 6 14/4 20 15/4 
7 85/42 88 7 13/5 18 13/4 
8 90/50 101 6 15/5 21 15/4 
9 78/62 105 7 17/6 20 18/6 
10 86/65 94 6 20/4 22 20/5 
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Table:10. One and a half ventricle repair model (n=10) 
After induced pharmacological stress test 
N0 BP HR RA RV SVC PA 
1 110/90 100 7 15/6 32 16/6 
2 115/80 116 8 16/4 36 16/4 
3 100/76 100 6 14/3 30 14/4 
4 100/80 110 8 15/2 32 15/2 
5 120/80 105 8 10/2 33 10/2 
6 116/92 120 5 12/3 34 12/4 
7 120/80 108 9 14/6 28 14/6 
8 110/70 110 5 13/6 32 14/6 
9 106/92 116 8 14/4 30 14/4 
10 112/96 118 6 14/3 30 15/4 
 
 Median SVC pressure: 1) at rest = 20 mmHg (R 18-25) 2) after stess : 32 
mmHg (R 28-36) >40%  
  Median RA pressure: 1) at rest = 7 mmHg (R 5-8)  2) after stess: 8 mmHg  
(R 5-9)  > 10% 
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Fig: 40. (C ) Group: cavopulmonary shunt alone (no.10) 
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Table:11. cavopulmonary shunt alone (no.10) 
Resting condition  
No. BP HR RA RV SVC PA 
1 72/40 90 7 18/7 8 18/8 
2 90/50 102 8 18/5 10 18/5 
3 83/40 86 7 20/5 12 19/5 
4 80/50 92 8 18/6 14 17/6 
5 94/56 76 7 15/5 12 15/5 
6 70/45 106 8 18/4 10 18/4 
7 85/42 88 9 17/5 12 18/5 
8 90/50 101 7 18/5 13 18/5 
9 78/62 105 8 17/6 14 18/6 
10 86/65 94 9 20/4 11 20/5 
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Table:12. cavopulmonary shunt alone (no.10) 
After induced pharmacological stress test 
No  BP HR RA RV SVC PA 
1  110/90 100 7 15/6 12 20/6 
2  115/80 116 9 16/4 14 16/4 
3  100/76 100 8 14/3 16 14/3 
4  100/80 110 10 15/2 17 15/3 
5  120/80 105 9 18/4 14 18/3 
6  116/92 120 11 20/4 12 20/4 
7  120/80 108 10 18/5 15 18/5 
8  110/70 110 8 20/5 16 20/5 
9  106/92 116 9 18/6 17 18/6 
10  112/96 118 10 22/4 15 23/4 
 
 Median SVC pressure: 1) at rest = 12 mmHg (R 8-14)  , 2) after stess test: 15 
mmHg (R 12-17)   >20% 
  Median RA pressure: 1) at rest = 8 mmHg (R 7-9)  , 2) after stess test: 9 
mmHg (R 7-11) > 11.1% 
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Fig:41. Pressure changes in control group; no any significant changes of blood pressure in SVC and RA after 
pharmacologically induced stress test 
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Fig:42. Pressure changes in 1.5 VR group; there is no any significant changes of RA pressure after 1.5 
ventricle repair at resting condition and after pharmacologically induced stress test. But after 1.5 VR we 
found elevated SVC pressure which increased significantly after pharmacologically induced stress test. 
----------------------------------------------------------------------------------------------- 
 
Fig:43. In group of Cavopulmonary shunt alone, found no any significant pressure changes in SVC and 
RA at resting condition and after pharmacologically induced stress test in comparison with 1.5 VR 
group.   
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3. SUMMERY OF ANIMAL STUDY  
1. After cavapulmonary anastomosis- SVC and PA pressure has increased but   RA    
pressure has decreased, which proves the decrease of the pressure in inferior vena cava 
district. 
2. After pharmacologically induced stress test:  increased the pressure in superior vena cava 
and also increased heart rate but  right ventricular, right atrial & pulmonary artery pressures 
were remained as same as after cavopolmonary anastomosis, as it is in resting condition. 
3. That means superior vena cava pressure is always higher after cavapulmonary 
anastomosis but venous pressure in inferior vena cava district is constant and even lower in 
comparison with preoperative pressure. 
4. We found no any changes of right atrial pressure, after 1.5 ventricular repair and even 
after pharmacologically induced stress test which proves that the inferior vena cava return is 
ok and no hypertension in inferior vena cava district even after stress test(good exercise 
tolerance), which is  a very positive finding in favor of one and a half ventricle repair in 
comparison to Fontan type procedures. 
4. Hemodynamic changes in superior vena cava  
1. After bidirectional cavapulmonary anastomosis increased the pressure in superior vena 
cava in 1.5 ventricle repair group in comparison with group with  cavapulmonary shunt 
alone (> SVC pressure in1.5 VR > CPS alone). 
2. At the resting conditions pressure in superior vena cava is higher in 1.5 ventricle repair 
group then in cavapulmonary shunt group and in control group. (>  SVC pressure in 1.5 
VR>  CPS alone > controls) 
3. After stress test in 1.5 VR group, pressure in superior vena cava increased two times more 
in comparison with cavopilmonary shunt group and control group: (> SVC pressure (1.5 VR 
>> CPS alone > controls)). 
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Fig: 44. Doppler from superior vena cava After 1.5 VR  (arrows: reverse systolic flow pattern) 
 
 
Fig:45. Doppler from superior vena cava after Fontan operation 
 
5.Right atrial pressure (which reflects the pressure in IVC) 
1. After cavopulmonary anastomosis right atrial pressure has found to be equal in all three groups: 
RA pressure (1.5 VR = CPS alone = controls) 
2. At resting conditions also right atrial pressure has found to be equal in all three groups: RA 
pressure (1.5 VR = CPS alone = controls) 
3. After stress test also we found the same condition, in all three groups right atrial pressure was 
found to be equal: RA pressure (1.5 VR = CPS alone = controls) 
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SECTION VI 
 
 
 
 
STUDY LIMITATION 
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Study limitation 
  
1. Animal model 
 
2. Normal size RV 
 
 
3.  No long term follow up (clinical+animal) 
 
4.   Desirable to have histopathological exams of the cerebral & hepatic  
      tissues to understand long term effect of the 1.5 ventricle repair at tissue 
      level. 
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SECTION VII 
 
 
 
 
 
CONCLUSION 
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CONCLUSION  
1. We found significant increase of the SVC pressure after 1.5 ventricle repair & after the 
pharmacologically induced stress test the pressure in superior vena cava has increased 
two times more than in resting condition. However, our experience of more than three 
decades in patients with Fontan type procedure, elevated SVC pressure is well tolerated. 
Similarly, Brain MRI of all our patients who underwent brain MRI with 1.5 ventricle 
repair showed good results at midterm fellow up. 
2. The 1.5 V repair is a valid option for surgical repair of hypoplastic, failing or borderline 
right ventricle. 
3. This repair provides  a low pressure in the inferior vena cava district and allows good 
early and mid-term outcomes 
4. Potential for right ventricle growth restoring the normal circulation. Valid alternative to 
Heart transplantation in severe right ventricle dysfunction. 
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SECTION VIII 
 
 
 
 
DISCUSSION 
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DISCUSSION   
Determining optimal repair strategy in a situation where one ventricle is functionally or 
anatomically marginal in size remains a challenge. The bias that a biventricular repair is 
always better than a single ventricle repair has been questioned by the finding that 
operative mortality for a complex biventricular repair can be higher than a single 
ventricle repair with similar anatomy.
91
 Mortality outside of the operative window may 
also be higher in complex biventricular repairs, as demonstrated by era independent 
late mortality in the Rastelli operation.
92, 93 
 For marginal left ventricles, a binary 
decision regarding the adequacy of the left ventricle is made. For marginal right 
ventricles, there is the opportunity to incrementally volume unload the right ventricle. 
53 
As compared with the requirements of a marginal systemic ventricle, the 1.5 ventricle 
repair, for hypoplasic or failing right ventricle, thus offers the considerable advantage of 
a variable volume load on the right while largely separating the systemic and pulmonary 
circulations. 
1, 2, 91, 94 - 99
 
The surgical management of patients with mild to moderate RV hypoplasia has 
improved, but the management of those with an RV where is too small to accommodate 
an entire cardiac output has been less satisfactory. 
1, 36, 99, 100
 The goals of surgical 
intervention for this group are to eliminate cyanosis by separating the pulmonary and 
systemic circulations while avoiding complications related to venous hypertension in 
inferior vena cava district. These goals are trying to met by using different modifications 
of Fontan type procedures or by establishing a right ventricle-to-pulmonary artery 
continuity and using a bidirectional cavopulmonary anastomosis to reduce the volume of 
systemic venous return that the RV must handle.
1, 36, 101
 Both these approaches have 
disadvantages. In the Fontan approach the main pulmonary artery generally is ligated, 
leaving a hypertensive RV with the potential to disturb the function of the systemic 
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ventricle or to cause arrhythmias.
98-105
 When a bidirectional cavopulmonary anastomosis 
is used, the blood flow from the inferior vena cava must pass through the tricuspid valve 
and RV to the pulmonary artery. Good results have been reported with this approach in 
patients with an RV volume as low as one third of the left ventricular volume.
71
 
However, if the RV and/or tricuspid valve are very small, inferior vena cava flow may 
be restricted. It can be difficult to predict whether the RV and/or tricuspid valve will 
accept the inferior vena cava blood flow because of difficulties in measuring RV volume 
and because valvar tricuspid stenosis is often associated with RV hypoplasia.
106
 An 
adjustable atrial septal defect 
1, 71
 or an atrial septal fenestration may maintain cardiac 
output and reduce central venous pressure but at the expense of some arterial 
desaturation. Alternatively, there may also be patients committed to a Fontan-type 
circulation with its long-term complications 
107, 108
 who may have benefited from 
inclusion of the RV into a repair. 
For these reasons, we studied alternative operative approach. By anastomosing the 
superior vena to right pulmonary artery and inferior vena cava blood has left to flow 
through the right ventricle to pulmonary artery. The hemodynamic consequences of an 
excessively small tricuspid valve and/or RV are thus avoided by "decompression" of the 
right atrium via the cavopulmonary anastomosis. If pulmonary vascular resistance is 
low, this procedure should accommodate the inferior vena cava return through right 
ventricle without any problem. Increases in inferior vena cava blood flow associated 
with normal growth and exertion should not result in excessively high right atrial 
pressure. 
By maintaining the RV in the atriopulmonary circulation, RV growth may continue and 
the pulsatile flow may enhance pulmonary artery growths. In these patients pulsatile 
flow provides to both lungs. The RV may contribute to pulmonary blood flow, imparting 
both kinetic energy and pulsatility.  
110 
 
A pulsatile pulmonary flow within pulmonary district may be advantageous in that 
vascular resistance to pulsatile flow is lower than to nonpulsatile flow, 
109, 110
 regional 
pulmonary blood flow may be more uniform, 
111
 and lymphatic drainage may improve. 
112
  The role of nonpulsatile blood flow in the development of pulmonary arteriovenous 
fistulae is more controversial.
113-117
 Exclusion of hepatic venous return from the 
pulmonary circulation may be associated with the formation of such fistulae in patients 
following a classic Glenn-type cavopulmonary anastomosis .
118, 119
 We hypothesize that 
establishing a communication between the inferior vena cava and the pulmonary arteries 
may be important in preventing pulmonary arteriovenous malformations. Longer follow-
up of patients in this series may shed some light on the question of which etiologic 
factor; pulsatile flow or hepatic vein origin of flow, is important in the pathogenesis of 
pulmonary arteriovenous fistulae, since those with the proximal right pulmonary artery 
interrupted have pulsatile flow in the left lung only, whereas hepatic venous blood 
reaches both lungs. 
Medium-term outcome after this operation is excellent, with no mortality and good 
functional status in all patient. All patients are acyanotic. Doppler echocardiographic 
studies demonstrated flow from the right atrium toward the pulmonary artery during 
atrial systole in all patients thus studied, indicating decompression of the right atrium 
during that part of the cardiac cycle. Flow from the inferior vena cava to the right atrium 
during the remainder of the cardiac cycle, forward flow across the tricuspid valve 
throughout ventricular diastole, and a discrete ventricular systolic flow jet across the RV 
outflow tract, which were seen in all patients.  
There is potential disadvantage to this operative approach; is that increased reverse flow 
to the superior vena cava but which was proved to be well tolerated by patients with 
Fontan procedure at midterm follow up. When the RV is very small, left pulmonary 
artery blood flow may be reduced or, if the RV is large and compliant, right pulmonary 
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artery flow may be reduced. Reduced pulmonary blood flow may have a detrimental 
effect on the growth of the pulmonary vascular tree.
120
 Unfortunately, reliable 
assessment of differential lung perfusion is difficult in this group of patients because of 
the multiple sources of pulmonary blood flow. Preoperative and postoperative branch 
pulmonary artery sizes were similar, but because the interval between operation and 
catheterization was relatively short, these measurements may not reflect growth in the 
more distal pulmonary vascular bed. 
In this relatively small group of patients, a continuation of  cavopulmonary anastomosis 
(between superior vena cava and right pulmonary artery)with the inclusion of the 
hypoplasic RV into the pulmonary circulation showed excellent short- and midterm 
results. Postoperative right atrial pressures were satisfactory, and there have been no 
significant atrial arrhythmias.  
Our animal study in 30 rabbits also showed well tolerated hemodynamic changes with 
increased pressure at SVC level with normal right atrial pressure after 1.5 ventricle 
repair, even after pharmacologically induced stress test. Which is  a very positive finding 
in favor of one and a half ventricle repair in comparison to Fontan type procedure for 
patients with hypoplasic, failing or borderline right ventricle. 
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